self-expanding luminal prosthesis

专利摘要:
LUMINAL PROSTHESIS AND GASTROINTESTINAL IMPLANT DEVICE. A luminal prosthesis comprises a first part that is adapted to be retained in a lumen and a second part that is connected to the first part such that a force applied to the second part is at least partially isolated from the first part. The second part can be adapted for mounting a device such as a valve. A connector between the first part and the second part may comprise at least one cable and/or at least one strut and/or at least one wire. In one case the first part and the second part are formed from a single precursor such as a continuous stent that is bent to form the first part and the second part.
公开号:BR112014014025B1
申请号:R112014014025-1
申请日:2012-12-19
公开日:2021-05-04
发明作者:Niall Behan
申请人:Coloplast A/S；
IPC主号:

专利说明:

INTRODUCTION
[1] The invention concerns a device. In one aspect the invention concerns a gastrointestinal implant device.
[2] There are several procedures and devices for treating obesity. Although many of these devices are successful in the short term, several problems can arise because the patient does not achieve an impression of satiety (fullness) after eating. STATEMENTS OF INVENTION
[3] According to the invention there is provided a luminal prosthesis comprising: a first part which is adapted to be retained in a lumen; and a second part which is connected to the first part in such a way that a force applied to the second part is at least partially isolated from the first part.
[4] The second part can be adapted for mounting a device such as a valve.
[5] The prosthesis may comprise a connector between the first part and the second part. The connector can comprise at least one cable. The connector can comprise at least one strut. The connector can comprise at least one wire.
[6] In one case the first part and the second part are formed from a single precursor.
[7] The precursor may comprise a continuous stent that is folded to form the first part and the second part.
[8] In one case the second part is radially within the first part.
[9] The first part may comprise a bulbous region.
[10] The second part may comprise a frame receiving region.
[11] The prosthesis may comprise a proximal flare. There may be a transition region between the bulbous region and the proximal enlargement.
[12] In one case, the prosthesis comprises a bulbous region, a proximal flare and a frame receiving region.
[13] Proximal flare may be of open mesh construction. The proximal flare can be adapted to resist axial movement of the prosthesis. The proximal flare can be at least partially coated. In one case the proximal flare has a peripheral region that is coated.
[14] In one modality the bulbous region is partially coated.
[15] In one case the frame receiving region is rigid in relation to the bulbous region.
[16] The prosthesis may comprise a transition region between the proximal enlargement and the bulbous region. The transition region can be of soft open-loop construction.
[17] The prosthesis may be of braided mesh construction.
[18] In one aspect the invention provides a luminal prosthesis comprising an outer region and an inner region connected to the outer region, the inner region being adapted for mounting a device such as a valve. The inner region can be connected to the outer region by connecting devices such as struts and/or wires. The inner region can be formed by an extension of the outer region. The inner region and outer region are formed by a continuous stent folded to form inner and outer regions. In one case the luminal prosthesis comprises a proximal flare, a bulbous region and a frame receiving region.
[19] In one modality the prosthesis is reinforced to facilitate radial compression during loading and to limit radial expansion. The reinforcement can extend around at least part of the circumference of the stent. The reinforcement can comprise at least one loop.
[20] In one case the reinforcement is non-swellable. Reinforcement can be of flexible material. In one case, the reinforcement is made of a polymeric or metallic wire. The reinforcement may be a material selected from one or more of the group comprising monofilament or braided polypropylene suture material or a stainless steel wire.
[21] The invention also provides a self-expanding luminal prosthesis having a reinforcement to facilitate radial compression during loading and to limit radial expansion. In one case the brace extends around at least part of the circumference of the stent. The reinforcement can comprise at least one loop. Reinforcement may be non-swellable. Reinforcement can be of a flexible material. The reinforcement can be of a polymeric or metallic thread. The reinforcement may be of a material selected from one or more of the group comprising monofilament or braided polypropylene suture material or a stainless steel wire.
[22] The invention also provides a gastrointestinal implant device comprising a prosthesis of the invention.
[23] Also provided is a gastrointestinal implant device comprising: a sleeve to extend into the duodenum; an artificial valve for placement in the pylorus to control flow from the stomach to the duodenal glove; and a support structure for the valve, the support structure comprising a frame to which the valve is mounted and a luminal prosthesis of the invention.
[24] According to the invention a luminal prosthesis is provided comprising an outer region and an inner region connected to the outer region, the inner region being adapted for mounting a device such as a valve.
[25] In one mode the inner region is connected to the outer region by a connecting device such as struts and/or wires.
[26] In another modality, the inner region is formed by an extension of the outer region. The inner region and outer region can be formed by a continuous stent folded to form inner and outer regions.
[27] In one case the luminal prosthesis comprises a proximal flare, a bulbous region and a frame receiving region
[28] The invention also provides a gastrointestinal implant device comprising a prosthesis of the invention.
[29] The invention provides a gastrointestinal implant device comprising: a sleeve for extending into the duodenum; an artificial valve for placement in the pylorus to control flow from the stomach to the duodenal glove; and a support structure for the valve, the support structure comprising a frame to which the valve is mounted and a luminal prosthesis of the invention.
[30] According to the invention there is provided a gastrointestinal implant device comprising: a sleeve for extending into the duodenum; and an artificial valve for placement in the pylorus to control flow from the stomach to the duodenal glove; and a support structure for the valve.
[31] The invention also provides a gastrointestinal implant device comprising: a sleeve to extend into the duodenum; an artificial valve for placement in the pylorus to control flow from the stomach to the duodenal glove; and a support structure for the valve, the support structure comprising a frame to which the valve is mounted and a luminal prosthesis, the luminal prosthesis comprising a proximal flare, a bulbous region and a frame receiving region.
[32] In one embodiment, the frame receiving region is located intermediate the proximal end and the distal end of the luminal prosthesis.
[33] The frame receiving region may be located between the proximal flare and the bulbous region.
[34] In one mode the valve is configured to open only when a pre-set back pressure in the valve has been exceeded.
[35] In one embodiment the support structure comprises a frame on which the valve is mounted. The support structure can comprise a luminal prosthesis.
[36] In one case the support structure comprises a frame on which the valve is mounted and a luminal prosthesis. The frame can be mountable so that it can be released from the luminal prosthesis.
[37] In one embodiment the glove is mounted on the support structure. In one case the sleeve is mountable so that it can be released onto the support structure. In one case the support structure comprises a frame and the sleeve is mounted on the frame.
[38] In one embodiment, the support structure comprises a stent-like structure.
[39] In one case the support structure comprises a stent-like frame.
[40] In one embodiment the support structure comprises a luminal prosthesis for positioning in the pylorus and a frame on which the valve is mounted, the frame being mountable so that it can be released into the pre-positioned luminal prosthesis. The frame can be releasably fit with the luminal prosthesis. The frame may comprise engaging elements which are releasably engageable with the luminal prosthesis. In one case the engaging elements comprise protrusions which are releasably engageable with the luminal prosthesis.
[41] In one embodiment, the luminal prosthesis comprises a mesh. The mesh can be covered with a coating. The lumps can fit with the mesh. Lumps can penetrate the mesh.
[42] In one embodiment the device comprises a release device for releasing the frame from the socket with a pre-positioned luminal prosthesis. The release device can comprise a means to reduce the diameter of at least a part of the frame. The release device may comprise a cord extending around the frame.
[43] There may be a first strand that extends around a proximal end of the support structure. There may be a second strand that extends around a distal end of the support structure.
[44] In one embodiment the valve is mounted on the support structure. The valve can be sutured to the support structure. The valve can be attached to the support structure. The valve can be glued to the support structure using adhesive.
[45] In one case a proximal end of the sleeve is mounted to the support frame. The glove can be sutured to the support structure. The sleeve can be attached to the support structure. The glove can be glued to the support structure using adhesive.
[46] In one embodiment the support structure comprises a frame that is of substantially uniform diameter.
[47] In one case the supporting structure comprises a luminal prosthesis.
[48] The luminal prosthesis may comprise a proximal flare. The luminal prosthesis may comprise a distal bulbous region. The luminal prosthesis may comprise a frame receiving region. The frame receiving region can be intermediate to the proximal and distal ends of the luminal prosthesis.
[49] In one embodiment, the glove is substantially uniform in diameter along its length.
[50] In another embodiment, the sleeve has a first diameter at a proximal end and a second diameter at the distal end that is larger than the first diameter. The glove can be tapered.
[51] In one embodiment the glove comprises a retaining device to help retain the glove in a desired location. The retaining device may comprise a retaining ring. A retaining ring can be placed at or adjacent to a distal end of the sleeve.
[52] There may be a plurality of retaining rings that are axially spaced side by side along the sleeve.
[53] In one case the retaining ring comprises a biasing device. The biasing device may comprise a flexible material which is biased to an expanded configuration.
[54] In one embodiment the retaining ring is oversized relative to the sleeve.
[55] The device may comprise release device for releasing the retaining ring from the socket. The release device may comprise a cord.
[56] In one modality the sleeve has a retracted delivery configuration and an expanded positioned configuration. The sleeve can be folded in the stowed delivery configuration.
[57] In one modality the valve has a normally closed configuration and an open configuration where the valve is open for stomach emptying.
[58] In one case the valve is adapted to automatically open for stomach emptying and to automatically return to the closed configuration.
[59] The valve may be a viscoelastic polymeric foam that may be biomimetic.
[60] In one embodiment the valve comprises an external support region, at least three valve leaflets, and a main body region extending between the support region and the valve leaflets. The valve may have a junction region of the valve leaflets in the closed configuration. The joint region can extend for an axial length of at least 1 mm.
[61] In one embodiment the device is adapted for placement in the sphincter or pyloric valve.
[62] In another embodiment, the device is adapted for placement distal to the pyloric sphincter.
[63] In one embodiment the bracket is adapted for mounting on a pre-positioned sleeve that extends into the duodenum.
[64] The invention also provides a delivery system for a gastrointestinal implant device, the implant device comprising an artificial valve, a duodenal sleeve and a support structure for the valve and sleeve, the device having a retracted delivery configuration and an expanded deployed configuration, the delivery system comprising a delivery catheter having a distal capsule for the implant device in the retracted configuration; and a glove positioning system.
[65] In one case the glove positioning system comprises: a distal cap; a fluid delivery lumen to extend through the sleeve; a distal seal between the distal cap and the lumen; and a proximal seal, whereby fluid delivery through the lumen and into the glove causes the glove to expand from an axially retracted delivery configuration to an axially expanded positioned configuration.
[66] The proximal seal can be seal-matchable with the sleeve for positioning the sleeve.
[67] The proximal seal can be sealingly fit with the valve for sleeve positioning.
[68] In one case the capsule is separable from the delivery catheter.
[69] The proximal seal may comprise an inflatable balloon.
[70] The distal seal may comprise an inflatable balloon. The delivery system can include a flexible tube to inflate the distal balloon.
[71] The delivery system in one embodiment comprises a positioner for positioning the support structure and the valve to which the support structure is mounted. In one case the positioner comprises a support. Support can be provided by a balloon. The positioner balloon may comprise the proximal balloon.
[72] In one embodiment the cap or distal plug is releasably mounted to the fluid delivery lumen.
[73] The invention also provides a gastrointestinal implant comprising a glove to extend into the duodenum, the glove having a pouch containing a radiopaque marker. The pouch may extend at least partially along the length of the glove.
[74] In one embodiment, the glove has a plurality of pockets for receiving a radiopaque marker.
[75] The radiopaque marker can comprise a fluid or gel. The fluid can comprise a silicon resin filled with a radiopaque material such as barium sulfate.
[76] The invention also provides a method of treating obesity and/or diabetes comprising the steps of: providing a luminal prosthesis; providing a valve mounted on a support frame, the valve having a retracted delivery configuration and an expanded positioned configuration; providing a coating glove to coat the duodenum; deliver the luminal prosthesis to a location in the pylorus or distal to it; position the luminal prosthesis at the location in the pylorus; deliver valve and support frame to location; and positioning the sleeve so that the sleeve extends from the valve and into the duodenum.
[77] In one embodiment the method comprises positioning the valve and support structure such that the support structure engages with the pre-positioned luminal prosthesis.
[78] In one modality, the luminal prosthesis is positioned in the pyloric sphincter.
[79] In another modality, the luminal prosthesis is positioned distal to the pyloric sphincter.
[80] The method may comprise releasing the valve support structure from engagement with the luminal prosthesis; and removing the valve support structure, valve and sleeve from location. The method may comprise repeating the appropriate steps to position a valve, valve support structure and sleeve in the desired location.
[81] The invention further provides a method of treating obesity and/or diabetes comprising the steps of: providing a valve mounted on a support structure; delivering the valve mounted on the support structure to a pre-positioned sleeve that extends into the duodenum; and positioning the valve such that the valve is mounted in the sleeve.
[82] The step of positioning the valve may comprise fitting the valve holder with the pre-positioned luminal prosthesis.
[83] In one case the valve support is an expandable support and the method comprises loading the support into a delivery catheter in a retracted fashion and the valve support is expandable in positioning. Support can be self-expanding. The support can be expanded by an expansion device such as a balloon.
[84] In one case the method comprises the step of releasing the valve support from the socket with the luminal prosthesis. The method may comprise repositioning the valve support within the sleeve. The valve can be removed from the sleeve.
[85] The invention also provides a gastrointestinal implant device comprising a pyloric valve for placement in the pylorus to control flow from the stomach to the duodenum, the valve being of a viscoelastic foam and comprising at least three valve leaflets, the valve having a configuration normally closed and an open configuration, the valve leaflets being movable from the closed configuration to the open configuration for flow from the stomach.
[86] In one mode the valve is adapted to automatically open for stomach emptying and to automatically return to the closed configuration. The valve may comprise an outer support region and a main body region extending between the support region and the valve leaflets. The valve may have a junction region of the valve leaflets in the closed configuration.
[87] In one case the device comprises an anchorage to anchor the valve to the pylorus.
[88] In one case the anchorage comprises a support structure for the valve. The anchorage may comprise a support frame for the valve and a luminal prosthesis to which the frame is mountable.
[89] In one case the device comprises a sleeve to extend into the duodenum. The sleeve can be mounted on the valve or on an anchorage for the valve. The device can be adapted for placement in the pyloric sphincter or it can be adapted for placement distal to the pyloric sphincter.
[90] According to the invention there is provided a gastrointestinal implant device comprising a valve for placement on the pylorus to control the rate of gastric emptying.
[91] In one embodiment the valve has a normally closed configuration and an open configuration where the valve is open for stomach emptying.
[92] There may be a support for the valve. The bracket can be adapted for mounting on a pre-positioned sleeve that extends into the duodenum.
[93] In one embodiment the implant device is adapted for placement in the pyloric valve.
[94] In an additional modality the implant device is adapted for placement distal to the pyloric valve.
[95] The valve support may comprise a support structure. The support structure can taper out. The support structure can taper inwards.
[96] In another case the support structure has a generally uniform diameter along its length.
[97] The support structure may comprise a frame.
[98] The support structure may comprise a stent-like structure.
[99] In one case the device comprises mounting features to mount the valve bracket to a pre-positioned luminal prosthesis.
[100] Mounting features can be releasably dockable with a pre-positioned host bracket.
[101] The device may comprise a release device for releasing the valve from the socket with a pre-positioned host support. The release device may comprise features for reducing the diameter of at least part of the valve support structure. The release device may comprise a cord extending around the valve support structure. There may be a first strand that extends around a proximal end of the support structure. There may be a second strand that extends around a distal end of the support structure.
[102] In one case the valve is mounted on the support structure. The valve can be sutured to the support structure.
[103] The valve can be joined to the support structure. The valve can be glued to the support structure using adhesive.
[104] In one mode the valve is adapted to automatically open in one direction.
[105] The invention also provides a method of treating obesity and/or diabetes comprising the steps of: providing a valve mounted on a support structure; delivering the valve mounted on the support structure to a pre-positioned sleeve that extends into the duodenum; and positioning the valve such that the valve is mounted in the sleeve.
[106] The step of positioning the valve may comprise engaging the valve holder with the pre-positioned luminal prosthesis.
[107] In one case the valve holder is an expandable holder and the method comprises loading the holder into a delivery catheter in a retracted fashion and the valve holder is expandable in positioning.
[108] Support can be self-expanding. Alternatively the support is expanded by an expansion device. The expansion device may comprise a balloon.
[109] In one embodiment the method comprises the step of releasing the valve support from the socket with the luminal prosthesis. The method may comprise repositioning the valve support within the sleeve.
[110] In one case the method comprises removing the valve from inside the sleeve.
[111] In one embodiment the valve comprises a polymeric valve body having an outer supporting edge, at least three valve leaflets, and a main body region extending between the supporting edge and the valve leaflets.
[112] The invention also provides a valve comprising at least four valve leaflets, the valve having a normally closed configuration in which the leaflets are engaged and an open configuration in which the leaflets are open. There can be at least five valve leaflets. There can be six valve leaflets.
[113] The valve may comprise a valve body of polymeric material. The valve may comprise an external support region. The valve may also have a main body region extending between the support region and the valve leaflets.
[114] In one case the main body region is generally concave between the outer supporting edge and a joining region of the valve leaflets.
[115] In one case the valve leaflets have a junction region and the valve body is reinforced at the junction region. The valve body can be thickened in the joint region.
[116] The junction region can extend for an axial length of at least 1 mm. The joint region can extend to a depth of 1 mm to 5 mm.
[117] In one embodiment the supporting edge of the valve body is reinforced. The supporting edge of the valve can be thickened.
[118] In one embodiment the valve comprises three valve leaflets.
[119] In another embodiment the valve comprises six valve leaflets.
[120] The valve can be mounted on the support structure.
[121] In one case the rim valve is sutured to the support structure. Alternatively or additionally the valve edge is glued to the support frame.
[122] In one embodiment, the support structure comprises a luminal prosthesis.
[123] In one case the luminal prosthesis extends proximally to the valve.
[124] In another case, the luminal prosthesis extends distally from the valve.
[125] In one embodiment, the luminal prosthesis extends proximally and distally from the valve.
[126] The luminal prosthesis may have a coating and/or a glove over it. The coating or glove may be on the outside of the luminal prosthesis. Alternatively the coating or glove is on the inside of the luminal prosthesis.
[127] In one modality the polymeric material is stable to gastric fluid for at least 3 months, for at least 4 months, for at least 5 months, for at least 6 months, for at least 7 months, for at least 8 months, for at least 9 months, for at least 10 months, for at least 11 months, or for at least one year.
[128] In one case the polymeric material absorbs less than about 5%, less than about 10%, less than about 15%, less than about 20%, less than about 25%, or less than about 30% by weight of water in balance.
[129] In one case the polymeric material of the valve body has an elongation percentage of 50% to 3000% or 200% to 1200%.
[130] In one case the polymeric material of the valve body has a tensile strength of 0.01 MPa to 5 MPa or about 0.1 MPa to 1.0 MPa, or about 0.25 MPa to 0 .5 MPa.
[131] In one embodiment the polymeric material has a Young's Modulus of about 0.01 MPa to 0.6 MPa, or from about 0.1 MPa to about 0.5 MPa.
[132] In one embodiment the polymeric material of the valve body has a density of 0.1 g/cm3 to 1.5 g/cm3, or 0.3 g/cm3 to 1.2 g/cm3, or 0 0.8 g/cm3 to 0.9 g/cm3, or from 0.5 g/cm3 to 0.6 g/cm3.
[133] In one modality the distance between the proximal end of the valve body support region and the distal end of the valve leaflets is less than 50 mm, or less than 40 mm, or less than 30 mm, or less than 25 mm, or less than 20 mm, or less than 15 mm.
[134] In one case the polymeric material of the valve body is an elastic material.
[135] In another case the polymeric material of the valve body is a viscoelastic material.
[136] In one embodiment the polymeric material of the valve body comprises a foam. The polymeric material of the valve body may comprise an open cell foam.
[137] In one embodiment the polymeric material of the valve body comprises a polyurethane foam.
[138] In one embodiment the valve is adapted to be mounted on a pre-positioned support structure, for example, an esophageal luminal prosthesis such as a stent.
[139] The invention also provides a valve having: a normally closed configuration in which the valve is closed: an open configuration in which the valve is open for flow through the valve; and a support for the valve, the support being adapted for mounting on a pre-positioned luminal prosthesis intermediate a proximal end and a distal end of the pre-positioned luminal prosthesis.
[140] In one case the luminal prosthesis has a coating and/or glove over it. The coating or glove may be on the outside of the luminal prosthesis. Alternatively or additionally the coating or glove is on the inside of the luminal prosthesis.
[141] Mounting device can be provided by the supporting structure. In one case the mounting device comprises protrusions extending from the support structure. The protuberances can be adapted to fit with a pre-positioned host esophageal luminal prosthesis.
[142] In one embodiment the bulge comprises a loop.
[143] In one case the apical tip of the bulge is rounded.
[144] There may be a release device to release the valve from the socket with a pre-positioned host luminal prosthesis. The release device may comprise features for reducing the diameter of at least part of the valve support structure.
[145] In one case the release device comprises a cord extending around the valve support structure. A first strand may extend around a proximal end of the support structure. A second strand may extend around a distal end of the support structure.
[146] In one embodiment the valve is mounted on the support structure. The valve can be sutured to the support structure. The valve can be attached to the support structure. The valve can be glued to the support structure using adhesive.
[147] In another case the mounting device comprises a surgical adhesive.
[148] The invention also provides a method of providing a valve in a body passage comprising the steps of: providing a valve mounted on a support structure; delivering the valve mounted on the support structure to a luminal prosthesis pre-positioned in the body passage; and positioning the valve so that the valve is mounted on the luminal prosthesis.
[149] In one embodiment the step of positioning the valve comprises fitting the valve holder with the pre-positioned luminal prosthesis.
[150] The valve holder can be mechanically fitted with the pre-positioned luminal prosthesis.
[151] In one case the valve holder comprises a bulge and the method comprises aligning the bulge with an opening in the endoluminal prosthesis and engaging the bulge in the opening.
[152] In one embodiment the valve support is an expandable support and the method comprises loading the support into a delivery catheter in a retracted fashion and the valve support is extensible in positioning.
[153] The mount can be self-expanding or the mount is expanded by an expansion device such as a balloon.
[154] In one embodiment the method comprises the step of releasing the valve holder from the socket with the luminal prosthesis.
[155] The method may involve repositioning the valve support within the prosthesis. The method may comprise removing the valve from within the prosthesis.
[156] In one embodiment, the luminal prosthesis extends proximally to the valve. The prosthesis may comprise a self-expanding plastic mesh. The prosthesis can apply a radial force of less than 1.9 kPa.
[157] In one modality there are anchors to mount the prosthesis in situ. Anchorages can be adapted to extend through the mesh of the prosthesis.
[158] In one embodiment the valve length from the proximal end of the support region to the distal end of the valve leaflets is less than 50 mm, less than 40 mm, less than 30 mm. The length of the valve can be approximately equal to the outside diameter of the valve support region. The valve length can be approximately 23 mm. BRIEF DESCRIPTION OF THE DRAWINGS
[159] The invention will be more clearly understood from the following description of the same given by way of example only, in which: Figure 1 is an isometric view (above) of a valve according to the invention; Figure 2 is an isometric view (from below) of the valve; Figure 3 is a top plan view of the valve; Figure 4 is a bottom plan view of the valve; Figures 5 and 6 are elevation views of the valve; Figures 7 and 8 are partially cut away isometric sectional views of the valve; Figures 9 and 10 are cross-sectional views of the valve; Figure 11 is a cross-sectional view of the valve in a normally closed configuration; Figure 12 is a cross-sectional view of the valve in an open configuration in response to a force; Figure 13 is a cross-sectional view of the valve returned to the closed configuration after opening for flow; Figure 14 is an isometric (top) view of the valve in a normally closed configuration; Figure 15 is an isometric view of the valve in a partially open configuration in response to a force; Figure 16 is an isometric view of the valve in a fully open configuration in response to a force; Figure 17 is an isometric view of a prosthesis; Figure 18 is an elevation view of the valve of Figures 1 to 16 being mounted and in position on the prosthesis of Figure 17; Figure 19 is another view of the valve mounted on a prosthesis; Figures 20 and 21 are isometric views of a sleeved or coated prosthesis; Figure 22 is an isometric view of the prosthesis of Figures 20 and 21 with the valve of Figures 1 to 16 in position; Figure 23 is an elevation view of part of the prosthesis of Figure 22 in position; Figure 24 is an isometric view of a valve in accordance with another embodiment of the invention; Figure 25 is an elevation view of the valve of Figure 24; Fig. 26 is an isometric view of another valve in accordance with the invention with a support structure tapering distally outward; Figure 27 is an elevation view of the valve of Figure 26. Figure 28 is an isometric view of another valve in accordance with the invention with a support structure tapering distally inward; Figure 29 is an elevation view of a luminal prosthesis with a valve and associated support structure in place; Figure 30 is an enlarged view of the luminal prosthesis and valve support structure of Figure 29; Figures 31 and 32 are enlarged views of an assembly detail of a valve support structure for a luminal prosthesis; Figures 33 to 37 are views of a valve being positioned by a delivery catheter; Figures 38 to 40 are views of an in situ luminal prosthesis with a valve being positioned in the lumen of the luminal prosthesis. Figure 41 is an elevation view of a valve according to another embodiment of the invention; Fig. 42 is an enlarged view of a detail of the support structure of the valve of Fig. 41; Figures 43 and 44 are isometric views of the valve of Figure 41 and 42 being positioned by a delivery catheter; Figure 45 is an elevation view of a prosthesis with the valve of Figures 43 and 44 in situ; Fig. 46 is an enlarged view of a detail of the fitting of the valve support structure of Figs. 41 to 45 fitted to the mesh of the prosthesis; Fig. 47 is an enlarged view of part of the luminal prosthesis and valve support structure of Fig. 46; Figure 48 is an elevation view of a luminal prosthesis; Figure 49 is an elevation view of an esophageal valve of the invention; Figures 50 to 55 are elevation views of steps involved in positioning the valve of Figure 49 within a pre-positioned luminal prosthesis of Figure 48; Fig. 56 is an elevation view of the valve of Fig. 49 positioned on the luminal prosthesis of Fig. 55; Fig. 57 is an elevation view similar to Fig. 56 with the valve being removed from the prosthesis in place; Fig. 58 is an isometric view of a valve in accordance with the invention; Fig. 59 is an elevation view of the valve of Fig. 56; Figure 60 is a plan view of the valve of Figures 58 and 59 with the valve in a closed configuration; Figure 61 is a plan view similar to Figure 60 with the valve in an open configuration; Figures 62 and 63 are side views of the device of Figure 60 with the valve in a closed configuration; Figures 64 and 65 are side views of the device of Figure 60 with the valve in the open configuration: Figure 66 is an illustration of a gastrointestinal implant device in accordance with an embodiment of the invention; Fig. 67 is an enlarged view of detail A of Fig. 66; Figures 68 and 69 are illustrations of another gastrointestinal implant device placed in the pyloric sphincter; Figures 70 and 71 are illustrations similar to Figures 66 and 67 with the device placed distal to the pyloric sphincter; Fig. 72 is an isometric view of a luminal prosthesis of an implant device of the invention; Fig. 73 is an elevation view of a valve, sleeve and frame part of an implant device; Fig. 74 is a cross-sectional view partially in elevation of an implant device with a prosthesis placed in a lumen such as the pylorus and a valve, sleeve and frame for mounting to the prosthesis; Fig. 75 is an elevation view of the assembled device of Fig. 72; Fig. 76 is an elevation view of the device of Fig. 75 with the sleeve extended; Fig. 77 is a cross-sectional view partially in elevation of the device, in situ; Fig. 78 is a view similar to Fig. 77 of an implant device with a sleeve in a folded delivery configuration; Fig. 79 is a view similar to Fig. 78 with the glove in another folded delivery configuration; Fig. 80 is a view similar to Fig. 79 with the glove in an additionally folded delivery configuration; Fig. 81 is a cross-sectional view partially in elevation of an implant device including a retaining ring for a glove; Fig. 82 is a view similar to Fig. 81 of another glove; Fig. 83 is a view similar to Fig. 81 with a sleeve having a plurality of retaining rings; Fig. 84 is a cross-sectional view illustrating a first stage in delivering an implant device to the pylorus; Fig. 85 is a cross-sectional view of the implant device in position with the sleeve in a retracted configuration; Fig. 86 is a cross-sectional view of the implant device in situ, with the sleeve partially extended; Fig. 87 is a cross-sectional view similar to Fig. 86 with the glove further extended; Fig. 88 is an enlarged cross-sectional view of a distal end of the delivery system; Fig. 89 is a cross-sectional view of the implant device in situ with the sleeve extended and the delivery system being removed; Fig. 90 is an elevation view of a delivery catheter for the implant device; Fig. 91 is a cross-sectional view of the delivery catheter of Fig. 90 with a capsule containing the implant device; Figures 92 to 94 are views showing the delivery system in various stages; Fig. 95 is a cross-sectional view of a proximal end of the delivery system capsule; Fig. 96 is an elevation view of part of the delivery system; Fig. 97 is an exploded view of part of the delivery system of Fig. 96; Fig. 98 is a graph of pressure profile over time with various orifice restrictors attached; Fig. 99 is a graph of pressure profile over time with a fixed orifice restriction and an implant device comprising a valve of the invention; Fig. 100 is a graph of pressure profile over time with a fixed orifice restriction and implant devices comprising valves of the invention; Fig. 101 is an isometric view of part of a glove in accordance with the invention; Fig. 102 is a cross-sectional view of the glove of Fig. 93; Fig. 103 is an isometric view of part of another glove in accordance with the invention; Fig. 104 is an isometric view of a luminal prosthesis in accordance with the invention: Fig. 105 is an isometric view of another luminal prosthesis in accordance with the invention; Figures 106 and 107 are views of a luminal prosthesis in which the inner and outer regions are connected by struts or wires; Fig. 108 and 109 are views of a continuous stent that has been folded or partially inverted to generate two coaxial regions; Fig. 110 is an illustration of longitudinal shortening of a stent resulting in migration from a valve device; Fig. 111 is views of a stent with restriction loops to restrict expansion of a section of a self-expanding stent; Figures 112 and 113 are views of stents with restriction loops; Fig. 114 is an isometric view of another luminal prosthesis in accordance with the invention; Figure 115 is a view of the prosthesis of Figure 114 with a valve and frame in position; Fig. 116 is a plan view showing the valve in a closed configuration; Fig. 117 is an isometric view of an in situ obesity treatment device incorporating the device of Figs. 114 to 116; Fig. 118 is an isometric view of a precursor for another luminal prosthesis in accordance with the invention; Fig. 119 is a view of the precursor of Fig. 118 being folded; Fig. 120 is a view of a luminal prosthesis formed from the precursor of Fig. 118; Fig. 121 is a view of the luminal prosthesis of Fig. 120 with a valve and frame in situ; Fig. 122 is an isometric view of an in situ obesity treatment device incorporating the device of Figs. 120 and 121; Fig. 123 is an isometric view of an additional luminal prosthesis in accordance with the invention; Figures 124 and 125 are diagrams illustrating different configurations of the prosthesis of Figure 123; Fig. 126 is a further isometric view of an additional luminal prosthesis in accordance with the invention; Figures 127 to 129 are diagrams illustrating different configurations of the prosthesis of Figure 126; Fig. 130 is an isometric view of an additional luminal prosthesis in accordance with the invention; Figure 131 is an isometric view of another luminal prosthesis in accordance with the invention: Figure 132 is a further isometric view of a further luminal prosthesis of the invention: Figure 133 is a partially lateral cross-sectional view of a device for treating breast cancer. obesity according to the invention; Figure 134 is an isometric view of a valve, inner support and sleeve of the device of Figure 33; Figure 135 is an isometric view of an external support of the device of Figure 133; Figure 136 is an exploded view illustrating the assembly of the valve, inner support and sleeve of Figure 134 to the outer support of Figure 135; Fig. 137 is a cross-sectional view of the obesity treatment device of the invention, in use; Fig. 138 is an enlarged cross-sectional view of the obesity treatment device in situ, in one configuration; and Fig. 139 is a view similar to Fig. 140 with the device in another configuration of use. DETAILED DESCRIPTION
[160] Referring to the drawings and initially to figures 1 to 16 thereof, a valve 1 that can automatically open in one direction is illustrated.
[161] Valve 1 comprises a polymeric valve body having a proximal outer support region with an edge 2, at least three valve leaflets 3, 4, 5, and a main body region 6 extending between the edge of support 2 and valve leaflets 3, 4, 5. Valve leaflets 3, 4, 5 extend inwardly and distally and terminate at distal end faces 7, 8, 9 respectively. Each of the handouts 3, 4, 5 has legs a, b that extend at an included angle of 120° to each other. Adjacent pairs of legs 3a and 4a, 4b and 5b, 5a and 3b join to close the space between the valve leaflets when the valve is in the normally closed configuration.
[162] Valve 1 has two configurations. The first configuration is a normally closed configuration in which valve leaflets 3, 4, 5 come together to close the valve. The second configuration is an open configuration in which the valve leaflets 3, 4, 5 are open in such a way that the leg pairs of leaflets 3a and 4a, 4b and 5b, 5a and 3b are open and spaced side by side in response. at a force F1 to allow flow through the valve.
[163] The various configurations of valve 1 are illustrated in figures 11 through 16. In the first or normally closed configuration (figures 11, 14) valve leaflets 3, 4, 5 come together. When a force F1 is applied to valve leaflets 3, 4, 5 the pairs of leaflet legs 3a and 4a, 4b and 5b, 5a and 3b open to allow anterograde flow to pass (figures 12, 16). Figure 15 illustrates a partially open configuration in response to flow. When force F1 is removed the leaflets 3, 4, 5 return to the closed position under the inherent bias of the polymeric material of the valve body (figure 13).
[164] Valve leaflets 3, 4, 5 are reinforced at the junction region. In this case, this is achieved by a local thickening of the polymeric material in this region. Similarly, the supporting edge 2 is reinforced by a local thickening of the polymeric material.
[165] The junction region of valve leaflets 3, 4, 5 has an axial extent that is typically 1 to 5 mm. This ensures positive binding of the leaflets across a significant interfacial area when the valve is in the normally closed configuration. The thickness of the leaflets at the junction region is typically between 0.1 mm and 10 mm.
[166] The valve body has a generally concave outer face and a generally convex inner face.
[167] Valve 1 of the invention returns to its original working position after being fully opened. This is accomplished without damaging the working valve.
[168] When the valve is opened via stomach emptying, the leaflets are opened.
[169] An important feature that influences valve function is the leaflet legs that collide with each other. By varying the geometry and length of leaflets 3, 4, 5 valve 1 can be made to open at different pressures. Aperture is also dependent on the elasticity and density of the material from which the device is made. Additionally, the overall diameter and the diameter to which the leaflets open influence the opening force.
[170] The valve can be any suitable biocompatible polymeric material. It can be a biocompatible polymeric material having properties that allow the valve to function as described.
[171] The materials used to produce this valve have an elongation percentage between 50% and 3,000%. The material also has a tensile strength between 0.01 MPa and 5 MPa. Additionally the material may have an antimicrobial action to prevent colonization when in the living body. Additionally the material can be elastic or viscoelastic and optionally can be an open cell foam. The density of the material should be between 0.1 g/cm3 to 1.5 g/cm3.
[172] The valve of the invention can be mounted on any suitable luminal prosthesis, especially a prosthesis or stent. The valve edge 2 provides a mounting ring for mounting inside the stent 20; for example, valve 1 can be mounted on the stent by suturing edge 2 to the stent mesh using the suture materials 21 as illustrated in Figures 18 and 19.
[173] The stent can be of any suitable type. An uncoated or sleeveless stent 20 is illustrated in Figures 17 to 19. Alternatively, if it is desired to prevent tissue growth into the stent a stent 30 having a sleeve 31 can be used (Figures 20 to 23). In this case, sleeve 31 is external to the stent. In other cases, alternatively or additionally, there may be an inner sleeve. Additionally, the stent can have a coating.
[174] A valve as described above can also be placed within a pre-positioned luminal prosthesis.
[175] In one case a valve 100 may have a coaxial support frame or frame 102 is shown in Figures 24 and 25. Frame 102 is designed to mate with any suitable esophageal stent 140 as illustrated in Figure 29. Engagement may be by protuberances which, for example, may be the proximal and/or distal apexes 103 of frame 102 which mate with the existing pre-positioned stent mesh 140. Alternatively or additionally, frame 102 may have features 150 designed to hook onto the inside of the struts of an esophageal stent as illustrated in Figures 31 and 32.
[176] Referring to Figures 26 and 27 a valve 110 according to another embodiment of the invention is illustrated wherein the support structure or frame 102 tapers distally outward such that the distal apexes 111 of the frame engage with the Existing pre-positioned host stent mesh 140.
[177] Referring to Fig. 28, another valve 120 according to the invention is illustrated in which the support structure or frame 102 tapers distally inward such that the proximal apexes 121 of the frame 102 engage with the mesh of a existing pre-positioned stent 140.
[178] The radial force of frame 102 can exert sufficient friction to hold the valve in place without the need for a bulge. In another embodiment a surgical adhesive can be used to secure the improved valve in place.
[179] Referring to Figures 33 to 37 a valve 100 is loaded into a delivery system 130 for positioning. The outer diameter of the delivery system 130 is smaller than the inner diameter of a pre-positioned esophageal stent 140. The delivery system 130 in this case comprises a delivery catheter having a distal capsule 131 within which a valve is housed in a configuration retracted. The catheter has a tapered distal tip 132 to prevent trapping a pre-positioned stent 140. Capsule 131 is movable axially relative to tip 132 to release the valve from within cap 131.
[180] Delivery system 130 is used to deliver the valve to a pre-positioned stent 140 as illustrated in Figure 38. The stent 140 has a mesh and the valve frame is adapted to mate with the mesh of the pre-positioned stent. positioned 140 at the valve release from within the delivery catheter as illustrated particularly in Figures 39 and 40.
[181] Referring to Figures 29 to 32 an idealized stent 140 with a valve support frame 102 in situ is illustrated. Details of a valve are omitted from these drawings for clarity. In this case, frame 102 is placed on the upper proximal end of the stent. In this case the frame 102 has hook-shaped elements 150 for engagement with the mesh of the stent 140 as illustrated in Figures 31 and 32. The engagement between the stent 140 and the frame 102 ensures that the frame 102 and therefore the valve is attached to it are retained in position and provides an antiproximal migration mechanism.
[182] In the cases illustrated the valve support frame 102 is of a self-expanding material such as a shape memory material, eg Nitinol. The valve and frame are loaded into delivery catheter capsule 131 in a compressed/reduced diameter configuration. When the capsule restriction 131 is removed at the placement site, the frame and valve expand to the normal configuration in which the frame is mated with the pre-positioned host stent 140. In some arrangements the frame may be of an expandable material that is expanded by an expander such as a balloon or the like.
[183] Referring to Figures 41 to 44 another valve device 151 according to the invention is illustrated which is similar to the one described above and like parts are designated with the same reference numerals. In this case valve 1 is housed within a support frame or frame 102 and is placed within the lumen of a stent 140 as illustrated in Figures 45 to 47. The support frame may comprise a relatively small length (typically 40 mm ) of a mesh made of a shape memory material such as Nitinol. The mesh can be formed by means of laser cutting and/or it can be of fabric construction. Positioning within the lumen of host stent 140 is via self-expansion from a radially collapsed state within a delivery catheter 130 as shown in Figures 43 and 44. Device 151 is held in place within stent 140 by means of delivery mechanisms. specific interactions that increase the axial friction of the support structure 102. Figures 45 to 47 illustrate the interaction with the host stent 140. In this embodiment, the support structure 102 has a series of loops or protrusions 155 extending perpendicularly from its surface. These bulges 155 fit with the structure of any host stent 140 by locking with the existing mesh as shown in Figures 52 and 53. The apical tip of each bulge 155 in this case is rounded or designed to be non-traumatic to any tissue that may contact the protrusion 155. The intrinsic radial strength of the support structure 102 as well as the flexural strength of the protrusions 155 interact to effect the retaining performance of the support structure 102. Thus the flexural strength or stiffness of the protrusion 155 and the Radial strength of the support structure 102 can be modified to change the locking ability and holding performance of the device. Valve device 151 is also readily collapsible radially via distal and proximal cords 170, 171. Distal cord 170 passes through grommets 172 mounted to support structure 102 at the distal end of valve device 151. Distal cord 170 has a accessible pull cord 173 which, upon being pulled, pulls cord 171 inward and thus reduces the diameter of the distal end of support structure 102. Similarly, proximal cord 171 passes through eyelets 175 mounted on support structure 102 at the end of the valve device 151. The proximal cord 171 has an accessible pull cord 177 which, upon being pulled, pulls the cord 171 inward and thus reduces the diameter of the proximal end of the support structure 102. The pull cords 173, 177 can be easily gripped using a suitable instrument such as a gripper to draw the proximal and distal ends of support structure 102 inwardly for ease. removal capability of the valve device 151.
[184] Referring to Figures 48 to 57, another valve device 200 according to the invention is illustrated which is similar to the one described above and like parts are designated with the same reference numerals. In this case valve 1 is housed within a support frame or frame 102 and is placed within the lumen of a stent 140 as illustrated in Figures 53 to 56. Support frame 102 may comprise a relatively small length (typically 40 mm) of a mesh made of a shape memory material such as Nitinol. The mesh can be formed by means of laser cutting and/or it can be of fabric construction. Positioning within the lumen of host stent 140 is via self-expansion from a radially collapsed state within a delivery catheter 130 as shown in Figures 50 to 55. Device 200 is held in place within stent 140 by means of delivery mechanisms. specific interactions that increase the axial friction of the support structure 102. Figure 56 illustrates the interaction with the host stent 140. In this embodiment, the support structure 102 has a series of loops or protrusions 155 extending perpendicularly from its surface. These protrusions 155 fit with the structure of any host stent 140 by locking with the existing mesh as shown in Figure 56. The apical tip of each protrusion 155 in this case is rounded or designed to be non-traumatic to any tissue that may enter. in contact with the protrusion 155. The intrinsic radial force of the support structure 102 as well as the flexural strength of the protrusions 155 interact to effect the retaining performance of the support structure 102. Thus the flexural stiffness or strength of the protrusion 155 and the radial force of the support structure 102 can be modified to change the locking capability and retention performance of the device.
[185] The valve device 200 is also readily collapsible radially via the distal and proximal cords 170, 171. The distal cord 170 passes through the grommets 172 mounted on the support frame 102 at the distal end of the valve device 200. The distal cord 170 has an accessible pull cord 173 which, upon being pulled, pulls cord 171 inward and thus reduces the diameter of the distal end of support structure 102. Similarly, proximal cord 171 passes through grommets 175 mounted on the support structure 102 at the proximal end of the valve device 200. The proximal cord 171 has an accessible pull cord 177 which, upon being pulled, pulls the cord 171 inward and thus reduces the diameter of the proximal end of the support structure 102. pulls 173, 177 can be easily grasped using a suitable instrument such as a gripper to draw the proximal and distal ends of the support structure 102 inwardly. the ease of removal of the valve device 200.
[186] It will be noted that in the case of this device 200 the diameter of the support frame is relatively uniform and the proximal and distal ends 201, 202 of device 200 are not tapered. It has been found that fitting the rounded protrusions 155 into defined interstices in the mesh structure of the stent 140 is sufficient to retain the device 200 in position within the stent 140. Typically, the diameter of the expanded support structure 102 will be slightly larger, for example , 1% to 5% larger than that of the host stent 140 at the desired deployment location to help maintain the frame 102 in situ.
[187] In some cases, as illustrated in Fig. 57, devices of the invention such as device 200 may revert to a radially collapsed state if it becomes necessary to reposition valve device 200 with stent 140 or withdraw device 200, by example, for replacement and/or replacement of the host stent 140.
[188] Thus, the possibility of valve collapse enables their optional removal by disengaging the protrusions 155 from the host stent 140, thus eliminating any axial friction associated with the host stent 140.
[189] The valve of figures 1 to 57 may be relatively short and is typically less than 30 mm, less than 25 mm, less than 20 mm, less than 15 mm, and typically about 10.6 mm long with a diameter of 18 mm outer rim or is about 11 mm long for an outer rim diameter of 20 mm.
[190] The valve can have any desired number of leaflets and, for example, valve 300 illustrated in Figures 58 through 65 has six valve leaflets 333. These leaflets 333 are oriented perpendicular to the direction of food flow to further allow for greater expandability of the valve opening.
[191] Referring to Figures 58 to 65 another valve device according to the invention is illustrated. Device 300 comprises a valve 301 that can automatically open in one direction.
[192] The valve 300 comprises a polymeric valve body having a proximal outer support region with an edge 302, six valve leaflets 303, and a main body region 306 extending between the support edge 302 and the valve leaflets 303. Valve leaflets 303 extend inwardly and distally and terminate at distal end faces 303 respectively. Each of the 303 brochures has legs that extend at an included 60° angle to each other. Adjacent pairs of legs join to close the space between valve leaflets 303 when the valve is in the normally closed configuration.
[193] Valve 300 has two configurations. The first configuration is a normally closed configuration in which valve leaflets 303 come together to close the valve. The second configuration is an open configuration in which valve leaflets 303 are opened such that the pairs of leaflet legs are opened and spaced apart in response to a force F1 to allow flow through valve 300.
[194] The various configurations of valve 1 are illustrated in figures 58 through 65. In the first or normally closed configuration the 303 valve leaflets come together. When a force F1 is applied to valve leaflets 303 the pairs of leaflet legs are opened to allow flow to pass. When force F1 is removed the leaflets 303 return to the closed position under the inherent bias of the polymeric material of the valve body.
[195] The 303 valve leaflets are reinforced at the junction region. In this case, this is achieved by means of a local thickening of the polymeric material in this region. Similarly, the supporting edge 302 is reinforced by a local thickening of the polymeric material.
[196] The junction region of the 303 valve leaflets has an axial extent that is typically 1 to 5 mm. This ensures positive binding of the leaflets across a significant interfacial area when the valve is in the normally closed configuration. The thickness of the leaflets at the junction region is typically between 0.1 mm and 10 mm.
[197] Valve body 306 has a generally concave outer face and a generally convex inner face.
[198] The valve 300 of the invention returns to its original working position after being fully open. This is accomplished without damaging the working valve.
[199] An important feature influencing the operation of valve 300 is the leaflet legs that collide with each other. By varying the geometry and length of leaflets 303 valve 300 can be made to open at different pressures. Aperture is also dependent on the elasticity and density of the material from which the device is made. Additionally, the overall diameter and the diameter to which the leaflets open influence the opening force.
[200] The valve can be any suitable biocompatible polymeric material. It can be a biocompatible polymeric material having properties that allow the valve to function as described.
[201] The materials used to produce this valve have an elongation percentage between 50% and 3,000%. The material also has a tensile strength between 0.01 and 5 MPa. Additionally the material may have an antimicrobial action to prevent colonization when in the living body. Additionally the material can be elastic or viscoelastic and optionally can be an open cell foam. The density of the material should be between 0.1 g/cm3 to 1.5 g/cm3.
[202] The valve 300 of the invention can be mounted on any suitable luminal prosthesis. The valve edge 302 provides a mounting ring for mounting inside the prosthesis; for example, valve 300 can be mounted to the stent by suturing edge 2 to the stent mesh using suture materials.
[203] Many emerging obesity treatments involve placing a tube inside the duodenum, which restricts the absorption of certain nutrients at this point in the body. The calorific deficit obtained then results in weight loss. Some of these devices can cause the pyloric valve to remain open for prolonged periods thus causing rapid emptying of the stomach. During episodes of rapid stomach emptying the feeling of fullness is shortened and the patient eats more.
[204] It has then been found that by placing a valve device on or near the pylorus that can controllably restrict the rate of stomach emptying an impression of fullness or satiety can be obtained.
[205] Referring to Figures 66 and 67 there is illustrated a valve device 500 that can be retrospectively placed within an existing obesity treatment device such as a glove 501 that extends from a stomach 502 into the duodenum. 503. A glove device such as this is described in US2005/0125075A, the entire contents of which are incorporated herein by reference. Valve 500 works to restrict the rate of stomach emptying. The positioning of valve 500 within a pre-positioned sleeve 501 is illustrated in Figures 66 and 67. Valve 500 may be of the type described above and may be attached to a frame 505 as described above.
[206] Referring to Figures 68 and 69 there is illustrated a valve 550 of the invention which in this case is placed in a pyloric sphincter 551 in order to control the rate of stomach emptying and thus provide an enhanced impression of satiety. This approach can be used, for example, in combination with a gastric band or other obesity treatment system. Valve 550 may be retained in situ by any suitable devices such as anchors 552.
[207] Alternatively, as illustrated in Figures 70 and 71, valve 550 may be placed distal to pyloric sphincter 551 to provide an additional valve acting in series with the valve or pyloric sphincter.
[208] Referring to Figures 72 to 77 there is illustrated a gastrointestinal implant device 600 comprising a sleeve 601 for extending into the duodenum and an artificial valve 602 for placement in the pylorus 603 to control flow from the stomach 604 to the duodenum which is covered by the duodenal sleeve 601. The device 601 also comprises a support structure for the valve. In this case the support structure comprises a frame 605 on which the valve 602 is mounted. The support structure also comprises a luminal prosthesis 606 on which the frame is mounted. In this instance, the frame 605 is mountable so that it can be released from the luminal prosthesis 606. The sleeve 601 is mounted on the support structure and in this case on the valve and/or frame 605.
[209] In this case the support structure comprises a stent-like frame 605 and the luminal prosthesis 606. The prosthesis 606 is for positioning in the pylorus and the frame 605 on which the valve 602 is mounted is mountable so that it can be released in the pylorus. pre-positioned luminal prosthesis 606. The frame comprises engaging elements which are releasably engageable with the luminal prosthesis 606. The engaging elements may comprise protrusions 607 which are releasably engageable with the luminal prosthesis. The luminal prosthesis 606 in this case comprises a mesh which may have a coating over it. The 609 protrusions can fit with the mesh and in some cases penetrate the mesh. In the case of an over-mesh coating, the protuberances 607 may penetrate the coating.
[210] In this modality at least a portion of the implant device is removable for complete removal, repositioning, or replacement. There is a release device for releasing the frame 605 from engagement with the prosthesis 606. The release device in this case comprises a device for reducing the diameter of at least part of the frame. The release device may comprise a strand 611 extending around the frame 605. In this case there is a first strand 611a extending around a proximal end of the support structure and a second strand 611b extending around a distal end of the support structure. For removal, the cords are tightened by pulling loops 612 using a suitable instrument such as a gripper.
[211] Both the 606 prosthesis and the 605 frame can be of a shape memory material such as Nitinol and have a reduced diameter delivery configuration and an expanded positioned configuration.
[212] The prosthesis 606 in this case comprises a proximal flare 620 for location in the expanded configuration in the antrum of the pylorus. Flare 620 helps to anchor the prosthesis in position. The prosthesis 606 in this case also has a distal bulbous region 621 which aids in anchoring the prosthesis in position. The prosthesis 606 has a frame receiving region 622 which in this case is intermediate to the proximal and distal ends of the prosthesis 606.
[213] Frame 605 has a proximal region 630 to accommodate valve 602 and a distal region 631 to accommodate sleeve 601 in a retracted delivery configuration. Valve 602 can be secured to frame 605 by suture materials 632 and/or can be joined, for example, by adhesive bonding to frame 605.
[214] The sleeve 601 in this case is also fixed to the frame 605 and/or the valve 602, for example, by means of glue and/or suture materials.
[215] Valve 602 has a normally closed configuration and an open configuration where the valve is open for stomach emptying. Valve 602 is adapted to automatically open for stomach emptying and to automatically return to the closed configuration. The valve may be a viscoelastic foam material such as the foam materials described in detail in this specification. Valve 602 in this case is similar to the valves described above and comprises an outer support region 640, at least three valve leaflets 641, and a main body region 642 extending between the support region and valve leaflets 641. valve 602 has a junction region 643 of the valve leaflets in the closed configuration to maintain the valve in the normally closed configuration. The junction region 643 may extend for an axial length of at least 1 mm.
[216] Figure 72 shows luminal prosthesis 606 in a loose preload configuration. Figure 73 shows frame 605, valve 602 and sleeve 601. Sleeve 601 is in a retracted configuration. Fig. 74 shows prosthesis 606 positioned in the pylorus and frame 605, valve 602 and sleeve 601 being inserted into prosthesis 606. Fig. 75 shows frame 605, valve 602 and sleeve 601 positioned within prosthesis 606. Figure 76 is a view similar to Figure 75 with the sleeve 601 expanded to a positioned configuration extending across the duodenum. Fig. 77 is a cross-sectional view showing valve 602, support frame and sleeve 601 fully positioned.
[217] It will be appreciated that the sleeve can be configured in different modes in a stowed delivery configuration. Some examples are shown in figures 78 to 80. In figure 78 the sleeve 601 is bent slightly like an accordion. In Fig. 79 the sleeve 601 can be folded longitudinally and subsequently can be in the form of a spiral wound. In figure 80 the sleeve 601 has creases or longitudinal folds and is also folded in on itself transversely.
[218] Sleeve 601 can have a constant diameter along the length of the sleeve, or it can be tapered (figures 81 and 83) or it can have a tapered proximal section and a distal section of constant diameter (figure 82).
[219] The 601 glove may have a retention device to help retain the glove in a desired location. For example, as illustrated in Fig. 81 glove 601 may have a retaining ring 650 at or near the distal end of the glove. There may be a plurality of such retaining rings 650 which may be spaced side by side along sleeve 601 as illustrated in Figure 83. Rings 650 may be of different size and/or shape to suit the target anatomy. Retaining rings 650 may have a biasing device to predispose the rings to an extended configuration. For example, retaining ring 650 may be oversized with respect to the diameter of sleeve 601. There may be a release device such as a cord or the like to release retaining ring 650 from the expanded positioned configuration.
[220] Referring to Figures 84 to 89 an implant device according to the invention and an associated delivery system are illustrated. The delivery system comprises a delivery catheter 660 with a distal capsule 669 which contains the frame 605, the valve 602 and the sleeve 601 in the retracted configuration. The delivery system includes a proximal expandable element provided by an inflatable proximal balloon 662 and a distal expandable element provided by a distal balloon 663. The proximal balloon 662 provides a temporary seal with the proximal end 664 of sleeve 601 on the proximal side of valve 602 Distal balloon 665 provides a temporary distal seal between a distal olive 666 and a distal end 667 of sleeve 601. An inflation fluid is introduced into sleeve 601 between proximal and distal balloons 662, 665, and the fluid causes the sleeve 601 expand axially to the expanded positioned configuration. When sleeve 601 is in the extended positioned configuration, distal balloon 665 is deflated, allowing dowel 666 to separate and displace distally. The remainder of the delivery system can then be withdrawn proximally, leaving the implant device in situ. Figure 84 illustrates the 605 luminal prosthesis or stent with a 30 mm wide proximal flare placed through the pylorus with the proximal flare resting on the pyloric antrum. An endoscope with a delivery system is advanced into the stomach. The delivery device is controlled via the axis of the endoscope and comprises a capsule that is positioned proximal to the endoscope. The capsule is advanced to the pre-placed stent. Figure 85 shows the stent, frame and valve with the sleeve in the retracted configuration. Distal dome 666 of the delivery system is also shown.
[221] Referring to Fig. 86, water is squirted through the delivery system to lengthen the plastic sleeve, which traverses the duodenum beyond the ligament of Treitz.
[222] Referring to Fig. 87, when the implant device is in place the delivery system is removed and the distal tip 666 traverses the bowel.
[223] In the case of the delivery system of Figures 84 to 89 the valve and frame are positioned before the sleeve is positioned. In this arrangement the proximal seal is provided by the proximal balloon which seals against the valve as illustrated in Fig. 87.
[224] Referring to Figures 90 to 97 another delivery system is illustrated. In this case the valve and frame are positioned after positioning the sleeve. In this arrangement the proximal seal is provided by the proximal balloon 662 which in this case seals against the inner wall of a distal capsule 669. The balloon 662 is not fully inflated in Figures 91, 92 and 94. A delivery catheter comprises an outer shaft 680 with a retraction hub 681 and an inner shaft 682. The shaft has several lumens and at the proximal end there are several ports connected to the lumens. There is a proximal sleeve inflation port 683, a distal tip balloon inflation port 684, and a proximal plunger or seal balloon inflation port 685. There is also a guidewire port 686 (which is shown in Fig. 96). ) for a guidewire 687. Fig. 97 shows the various lumens, i.e. a 690 water injection lumen for glove positioning, a 691 proximal balloon inflation lumen, a 692 distal tip balloon inflation lumen, and a guidewire lumen 693. A flexible tube 688 extends through a lumen 689 within the inner shaft 682. The flexible tube 688 also extends through the proximal balloon 662 which in this case is threaded. Tube 688 has an outlet for inflating balloon 665.
[225] Referring to Fig. 90, the capsule 669 is mechanically releasable from the outer shell, for example, by means of a 695 screw thread connection. In use, the delivery system shaft is inserted through the proximal end of a channel. delivery of an endoscope. When the distal end of the delivery shaft exits the distal end of the endoscope delivery channel the capsule is mounted to the distal end of the delivery shaft using mechanical fixation which in this case is a screw fixation.
[226] In Figure 90 the sleeve/valve/frame implant device is in the stowed delivery configuration. Flexible tube 688 extends to tip balloon 665 and has a hole through which air is delivered for inflation of balloon 665. Tube 688 is of a suitable flexible material such as a plastic, eg, nylon.
[227] Referring to Fig. 92, proximal balloon 662 is inflated to seal sleeve 601 at the proximal end and distal balloon 665 is inflated to seal sleeve 601 at the distal end. Water is then drained into the retracted sleeve 601 and, because of the seals 662, 665 at the proximal and distal ends, water fills the sleeve 601, causing it to extend. Sleeve 601 is shown in a partially extended configuration in Figure 92.
[228] When sleeve 601 is fully extended (Fig. 93) distal balloon 665 is deflated, allowing tip 666 to be released into bowel for discharge. Proximal balloon 662 remains inflated and acts as a plunger to position the frame from capsule 669. Frame 605 engages with stent 606 as described above and the delivery system is withdrawn as illustrated in Figure 94.
[229] Figure 95 illustrates the proximal delivery components. Retract hub 681 is connected to outer shaft to enable pullout of outer shaft 680 over inner shaft 682.
[230] Figure 98 is a graph of the pressure profile of orifice restrictors fitted with orifices of various sizes. Constraints were created using a 1 mm thick polyethylene membrane. Each hole was created by drilling to the desired hole size followed by verification using a Vernier gauge. The flow rate through the test apparatus was controlled at 7.86 g/s with a fluid having a viscosity of 39,000 Cps. It will be appreciated that when a series of orifice restrictors of fixed diameters are used to impede fluid flow the resulting back pressures generated have a characteristic pattern. Back pressure initially increases markedly followed by a sustained gradual pressure rise until flow is stopped. This behavior is illustrated by figure 98 for 4mm, 5mm and 6mm diameter constraints. This is undesirable for use as a gastric flow restrictor because a constant rise in pressure as a function of flow can give rise to adversity and gastric paralysis.
[231] Figure 99 is a pressure profile of several different constraints. The 6mm orifice is made as described above for Fig. 98. The pressure profile represented by dashed line is generated using a leaflet valve as described above with reference to Figs. 58 - 65. viscoelastic foam. The foam material in this case is a material described in Example 5 of the Group 1 materials described below. The material density was 0.9 g/ml. It can be seen from Fig. 99 that a combination valve of parts of the foregoing description enables the generation of a constant back pressure over the duration of fluid flow. The valve is thus adapting to the fluid flow to maintain a constant restrictive force independent of fluid flow through it.
[232] Valve performance can be adapted by adjusting the material density, and this, for example, can be achieved by introducing more or less material into the valve forming mold, which subsequently expands to fill the cavity. Referring to figure 100, the valve was made using the same material as in figure 99, but in this case the density was changed to approximately 0.76 g/ml. Through this modification it was possible to produce a valve that initially generated a high back pressure and subsequently adapted to the fluid flow, thus decreasing the back pressure. A valve like this has an initial barrier function followed by a steady state restriction. The valve prevents flow to a predetermined set point pressure, after which the back pressure remains substantially constant, thus providing a predictable stomach emptying rate.
[233] Various materials can be used to manufacture the sleeve portion of the device. These materials can be, for example, polyethylene, PTFE or FEP because of their low friction, thus not impeding fluid flow through them.
[234] Referring to Figures 101 and 102, a glove 750 in accordance with the invention features to make visible glove placement using a radiopaque marker. A radiopaque ink or color is used. Due to the chemical nature of glove materials the adhesion of a coating is very difficult. A longitudinal pocket 751 is provided which can be created by overlaying a portion of the glove material. Within this pouch 751 a radiopaque material 752 such as a liquid silicon resin filled with BaSO4 is deposited, which is subsequently cured. This allows for a low profile and a fluoroscopically distinguishable marker for visualization in the body. Referring to Fig. 103, in this case the glove has a plurality of pockets 760 which can be arranged in any desired mode to facilitate viewing, for example, in particular locations.
[235] The duodenum begins at the pylorus and forms a curved region just distal to the duodenal bulb. This region, known as the descending duodenum, is where chyme begins to mix with digestive secretions from Vater's ampoule. As chyme begins to digest it is absorbed by the luminal surface of the duodenum. The glove works to bypass this absorption mechanism. The length of the glove liner may be sufficient to reach the distal duodenum coinciding with the ligament of Treitz, where the duodenum meets the jejunum. Alternatively the glove may be smaller and the inhibition of absorption through the duodenal lumen will be proportional to the glove length. Since most adsorption in the duodenum takes place between the ampoule of Vater and the jejunum, the glove must be at least long enough to pass through the ampoule. Furthermore, when the glove does not extend into the ligament of Treitz, the glove is delivered more easily as no displacement is required through the tortuosity of the ligament of Treitz. The typical length of the glove can be from 40 cm to 45 cm.
[236] Fig. 104 is an illustration of a luminal host prosthesis or stent 800 in accordance with the invention. Stent 800 comprises a funnel-shaped region 801 to be placed in the antrum of the stomach. The host stent shown in Figure 84 also has a funnel-shaped region to be placed in the antrum of the stomach. A funnel-shaped or enlarged region such as this ensures that chyme flows through the stent lumen and not around the stent's outer surface. This is important as chyme being forced around the exterior of the stent can cause compression and migration of the stent.
[237] The funnel region 801 is connected to a narrower, softer region 802 that is designed to pass through the pylorus. This 802 region is sufficiently compliant to allow the pylorus to close in response to physiological pressures.
[238] This softer 802 region also has a feature to allow coaxial attachment of an obesity device such as a valve as shown in Figure 77. Attaching an obesity device to the proximal part of the stent is important. By this methodology any drag force experienced by the obesity device because of food passing through the lumen can be transferred to another region(s) of the stent such as a bulbous distal 803 region of the stent. The resulting compressive force can expand into the bulbous region(s) 803 of the stent structure, thereby enhancing stent retention.
[239] Connecting the 803 bulbous region to an 801 transpyloric funnel helps locate the stent in the anatomy and prevent rotation of the 803 bulb perpendicular to the geometric axis of the duodenal lumen.
[240] The stent may also have a cylindrical region 804 that connects to the distal end of the bulbous region 803 for contact with the tubular lumen of the duodenum.
[241] The stent is a self-expanding stent. The self-expanding stent can be produced by knitting, braiding, or weaving. In one case the stent is a braided structure.
[242] Self-expanding braided or knitted stents can be made of metal or synthetic polymers. If made of metal, a superelastic alloy is usually chosen because of the desired mechanical properties. These stents can be designed to exert significant radial force, but at the same time to be adaptable and allow for the natural mechanical processes of digestion.
[243] The technology can be used most appropriately in the gastrointestinal tract as described above.
[244] One of the advantages of braided or knitted stents is that their radial diameter can be easily reduced to allow for coating and delivery. This property is important when the stent is to be introduced into a narrow-body lumen or even through the accessory channel of an endoscope.
[245] However, because of the tissue structure, the reduced-diameter stent is often substantially longer than when its diameter is allowed to return to its nominal state. This in turn causes a problem during placement as the stent shortens as it expands radially, making precise placement a challenge. The user of such stents must always balance the advantages of their clinical benefits with the difficulty of delivery.
[246] Because of the interrelationship between the length and diameter of these stents, any force on the body that causes them to elongate will cause their diameter to decrease. This mechanical behavior will ultimately result in loss of contact with the body lumen causing migration. Conversely, any force on the body that causes the stent to shorten longitudinally will result in an axial expansion, thereby reinforcing the stent's position in the body lumen.
[247] A stent such as this can elongate when relative tractive force is applied to both ends and can shorten when compressive force is applied to both ends.
[248] There are situations in which the use of a valve on a self-expanding stent may be desirable and anatomical considerations may dictate that the valve be placed at the proximal or distal end of the stent. A valve can experience a drag force from the flow of food through its lumen. If the valve is placed at the distal end of the stent, a pulling force can be created by the flow of food through the stent, while a compressive force can be created if the valve is placed at the proximal end of the stent.
[249] Although the latter is more desirable from a retention standpoint, it may not always be possible to position a valve at the proximal end of the stent. It follows that valves placed at the distal end of the stent give rise to a high risk of migration.
[250] The invention provides methodologies for transferring forces, experienced by distally placed valves, to the proximal region of a stent. Thus, a proximally placed valve can be made to exert a compressive force on the stent.
[251] The invention can be broadly described as follows: a stent having an outer region 851 for contact with the body lumen, an inner region 852 for contact with a valve (or a prosthesis such as this) and a component of connection to connect the inner region to the proximal part of the outer region. One embodiment is illustrated in Figure 105. The outer region may be contoured to fit with the appropriate body lumen. The dimensions indicated in Fig. 105 are particularly suitable for a prosthesis which is to be placed in the antrum of the stomach and extend through the pylorus.
[252] The connection region can be formed by means of struts, wires or other distinct structures 853 as shown in Figures 106 and 107. Alternatively, the inner and outer regions can be formed by a continuous stent bent to form the regions coaxial internal and external 851, 852 of Figures 108 and 109.
[253] There are situations in which the placement of a valve and support structure on an already positioned self-expanding stent (host stent) may be desirable. Such a valve component can anchor itself to the host stent through radial force, friction, or some mechanical interlock mechanism.
[254] Any forces exerted on the stent and valve system that cause the stent to shorten and compress will result in an expansion of its diameter. This behavior will likely cause any coaxially located valve component to disengage from engagement with the inner lumen of the stent and thus migration would occur as shown in Figure 110. Figure 110 illustrates longitudinal shortening of an 825 stent (such as a braided stent) resulting in migration from a valve device 826.
[255] One aspect of the invention involves adding a loop or series of non-expandable loops 820 to the circumference of a self-expanding stent restricting expansion of a section of a self-expanding stent as shown in Figures 111, 112 and 113. The loops 820 which can be made of a flexible material such as a polymeric or metallic wire allow radial compression of the stent during loading, but limit radial expansion to the predetermined diameter of the loop. Exemplary materials are monofilament or braided polypropylene suture materials or stainless steel wires.
[256] When using this methodology the valve component, which can be placed within the region with added loops, will not be displaced by any longitudinal forces on the stent.
[257] Referring to Fig. 114, another endolumenal prosthesis 900 in accordance with the invention is illustrated. The prosthesis is similar to the prosthesis of Fig. 113 and like parts are designated with the same reference numerals. The prosthesis is of braided mesh construction and comprises a proximal flare or umbrella-like region 801, a bulbous region 803 and a duodenal region 804. A transpyloric region 901 interconnects the proximal flare 801 around the bulbous region 803.
[258] The proximal 801 umbrella-like region is open mesh and is relatively soft to avoid tissue irritation. The periphery of the proximal flare in this case is at least partially coated with a suitable coating material. The coating in this region serves as a positioning aid as it prevents gripping between adjacent regions when the stent is in a collapsed delivery configuration. Folding the flare distally provides some axial drag that provides resistance against dislodgement in use, for example, when placed on the pylorus.
[259] The transpyloric region 901 is too soft and flexible to resist transmission of force from the proximal flare 801 to the bulbous region 803. The transpyloric region may be uncoated to allow some tissue growth into it.
[260] The bulbous region 803 acts to aid device retention by engaging the duodenal bulb. The mesh is flexible in this region to adapt to the anatomy in which it is placed. An underside of the bulbous region 803 can be coated to prevent tissue growth into it.
[261] The duodenal region 804 is designed in such a way that its diameter will not expand beyond a predefined limit. The braid/mesh has a weave that is denser than the other regions as the duodenal region in this case is the region in which a valve 602 and associated frame 605 are positioned, as illustrated in Figures 115 to 117. The valve and frame may be, for example, as described above - such as those described with reference to figures 73 to 97.
[262] Figure 120 illustrates another luminal prosthesis 925 according to the invention, which has some features similar to the prosthesis of figure 109 having the inner and outer coaxial regions 851, 852. In this case the inner and outer regions 851. 852 are formed by a continuous precursor stent 935 (Fig. 118) that is folded as shown in Fig. 119. The inner region 852 in this case is adjacent to the proximal end of the prosthesis and a frame and valve of the types described above can be easily positioned. Figure 121 shows the luminal prosthesis of Figure 120 with a valve and frame in situ. Figure 122 illustrates an obesity treatment device according to the invention in situ incorporating the device of Figures 120 and 121. The arrangement ensures that any movement of the valve is effectively isolated from any shortening or otherwise of the outer region of the stent. .
[263] Another luminal prosthesis 928 according to the invention is illustrated in Figures 123 to 125. This prosthesis 928 is similar to the prosthesis of Figure 107 and Figures 124 and 125 illustrate how the inner part of the prosthesis is at least partially isolated from the outer part because of connection 853 which, for example, can define a region of at least partial articulation.
[264] Figure 126 illustrates another luminal prosthesis 925 according to the invention which is somewhat similar to the prosthesis of Figure 109. The operation of the prosthesis 925 is illustrated diagrammatically in Figures 127 to 129.
[265] A similar prosthesis is shown in Figure 126 and the operation of the device is illustrated diagrammatically in Figures 127 to 129.
[266] In some cases, as illustrated in Figures 130 and 131, there may be an additional axially flexible connector such as at least one cable 930 between the inner and outer parts.
[267] Referring to Fig. 132, in this case a prosthesis 950 comprises a bulbous portion 951 that is separated from a proximal flare portion 952. The portions 951 and 952 may be interconnected by any suitable connector(s). s) 953 such as at least one cable. The proximal flare may have a partial transpyloric region in which a valve/frame may be mounted.
[268] Referring to Figures 133 to 139, another obesity treatment device 960 in accordance with the invention is illustrated. Device 960 comprises an outer bracket 961, a valve 962 mounted on an inner bracket 963, and a sleeve 964 which extends in use into the duodenum as described above.
[269] The outer bracket 961 has a proximal flare portion 970 and a distal bulbous region 971. The distal bulbous region and the proximal flare region are connected by a cylindrical transpyloric region. The radial force of the cylindrical region is low to allow normal functioning of the pyloric sphincter. The proximal flare portion 970 is of open mesh construction and does not require a liner. It fits with the antrum of the stomach that holds it in place. At least a distal portion of the bulbous region 971 of the outer bracket 961 is coated.
[270] Valve 962 mounts to inner bracket 963 and inner bracket 963 in turn is mated with the coated distal portion of bulbous region 971 of outer bracket 961. Inner bracket 963 has integral rings 972 that fit into the mesh of the 961 external support to help retain the 963 frame in situ. The inner support 963 is free to displace relative to the outer support 961, but does not impinge on the duodenal bulb tissue.
[271] In use, when food is leaving the stomach through valve 962 a proximal portion of the inner frame 963 shifts relative to the outer support 961, which causes axial force to be translated both distally and radially. The resulting force vector increases the radial force on the outer support 961 and absorbs axial force. The proximal portion of the inner bracket 963 can displace axially distally because it is not coupled to the outer bracket 961. The distal portion of the inner bracket 963 only interacts with the outer bracket 961 and does not extend through the outer bracket 961. The bracket internal 961 does not fit with the wall of the duodenal bulb.
[272] The obesity treatment device does not interfere with pyloric sphincter function. The pylorus functions normally while ensuring the device is anchored in place. When food is passing through the valve the applied force is translated into a radial force on the duodenal bulb that is malleable enough to distend and absorb this force. The device works to delay stomach emptying to give the user a prolonged feeling of satiety.
[273] Over the past few years there has been a significant increase in commercial activity related to implantable devices to treat obesity. Some of these devices are intended for use in the pylorus and duodenum and thus require some form of retention. Current retention modalities include the use of tissue penetrating barbs, which create ulceration and pain. This gastrointestinal implant device prevents the use of such barbs.
[274] This technology will find commercial application in the emerging area of obesity treatment to improve retention of devices that will be exposed to the high forces associated with food flow through the gastrointestinal tract.
[275] Various technologies that may be suitable for use in or in association with the device of the invention are described in the following US patent applications: USSN 12/488,037 (published as US2010-0121462A); USSN 12/488,016 (now US8029557); USSN 12/487,991 (published as US2010-0121461A); USSN 12/971,458 (published as US2011-0190905A); USSN 13/493,904 (published as US2012-0310138A); and USSN 13/329,728 (published as US2012-0158026A), the entire contents of which are incorporated herein by reference.
[276] A first group of biomaterials that are suitable for fabricating a valve of the invention is described in our application USSN 12/488,047 (now US7932343) and in WO2009/153769, the entire contents of which are incorporated herein by reference. A second group of biomaterials that are suitable for manufacturing a valve of the invention is described in our application USSN 12/971,384 (published as US2011-0152395A) and in WO2011/073967A, the entire contents of which are incorporated herein by reference.
[277] Several features of the invention are described and illustrated in detail in this document. Appropriate features described with reference to one modality may be used in addition to features described in other modalities and/or as a substitute for them.
[278] The invention is not limited to the embodiments described above with reference to the accompanying drawings, which may be varied in construction and detail.

权利要求:
Claims (7)
[0001]
1. A self-expanding luminal prosthesis (800) comprising: a stent comprising: a first outermost portion comprising a distal bulbous region (803) that is adapted to be retained in a lumen; a second innermost part provided radially within the first part comprising a region (802) which is softer than the remainder of the stent and is adapted for mounting a valve; a proximal flare (801); and a connector (853) between the first part and the second part at least partially isolating the second innermost part from the first outermost part so that a force applied to the second part is at least partially isolated from the first part, wherein the region softer (802) has means to allow coaxial connection of a valve; and the distal bulbous region (803) is allowed to expand, thus reinforcing the retention of the stent, characterized by the fact that the stent further comprises an additional axially flexible connector with at least one cable (930) between the inner and outer parts.
[0002]
2. Prosthesis (800) according to claim 1, characterized in that the proximal enlargement (801) is of open mesh construction, and the proximal enlargement (801) is adapted to resist axial movement of the prosthesis.
[0003]
3. Prosthesis (800), according to any one of the preceding claims, characterized in that the proximal enlargement (801) is at least partially coated, and the proximal enlargement (801) may have a peripheral region that is coated.
[0004]
4. Prosthesis (800), according to any one of the preceding claims, characterized in that the bulbous region (803) is partially coated.
[0005]
5. Prosthesis (800), according to any of the preceding claims, characterized by the fact that the frame receiving region is rigid in relation to the bulbous region.
[0006]
6. Luminal prosthesis (800), according to any one of the preceding claims, characterized in that the softer region (802) between the proximal enlargement (801) and the bulbous region (803) is of soft open mesh construction .
[0007]
7. Prosthesis (800), according to any one of the preceding claims, characterized in that the luminal prosthesis is of braided mesh construction.

类似技术:

---

公开号 | 公开日 | 专利标题

---

US10973668B2|2021-04-13|Valve device

---

ES2503553T3|2014-10-07|Modular Gastrointestinal Prosthesis

---

ES2430964T3|2013-11-22|Administration system and branched vessel grafting method

---

EP1968506B1|2011-09-14|Coiled intragastric member for treating obesity

---

US8114045B2|2012-02-14|Apparatus and methods for delaying gastric emptying to treat obesity

---

KR101814855B1|2018-01-04|Improved surgical implant devices and methods for their manufacture and use

---

US20070027525A1|2007-02-01|Vascular implant

---

EP3423128B1|2021-11-03|Pyloric anchors and methods for intestinal bypass sleeves

---

WO2012080997A1|2012-06-21|A gastrointestinal implant device

---

KR20180050286A|2018-05-14|A stomach device including a rounded member at the distal end and an expandable duodenal anchor and use thereof

同族专利:

---

公开号 | 公开日

---

US20180338849A1|2018-11-29|

---

JP2019202184A|2019-11-28|

---

CN106963530B|2020-08-21|

---

CN106963530A|2017-07-21|

---

US20140350694A1|2014-11-27|

---

RU2014123537A|2016-02-10|

---

WO2013092715A2|2013-06-27|

---

AU2018201323A1|2018-03-15|

---

JP2015500705A|2015-01-08|

---

US10195066B2|2019-02-05|

---

CN104114128A|2014-10-22|

---

US10973668B2|2021-04-13|

---

AU2012357751A1|2014-07-03|

---

AU2012357751B2|2017-12-14|

---

WO2013092715A3|2013-08-22|

---

JP6853312B2|2021-03-31|

---

RU2626885C2|2017-08-02|

---

CA2858301C|2021-01-12|

---

CA2858301A1|2013-06-27|

---

BR112014014025A2|2017-06-13|

---

EP2793765A2|2014-10-29|

---

CA3100305A1|2013-06-27|

---

EP3888602A1|2021-10-06|

---

AU2018201323B2|2018-10-18|

---

EP2793765B1|2021-02-17|

---

JP2017170238A|2017-09-28|

---

JP6175069B2|2017-08-02|

引用文献:

---

公开号 | 申请日 | 公开日 | 申请人 | 专利标题

---

---

GB1354691A|1970-02-12|1974-05-30|Black M M|Fluid-operated valves|

---

US4265694A|1978-12-14|1981-05-05|The United States Of America As Represented By The Department Of Health, Education And Welfare|Method of making unitized three leaflet heart valve|

---

US4271827A|1979-09-13|1981-06-09|Angelchik Jean P|Method for prevention of gastro esophageal reflux|

---

US4603152A|1982-11-05|1986-07-29|Baxter Travenol Laboratories, Inc.|Antimicrobial compositions|

---

FR2600524B1|1986-01-13|1991-10-18|Galtier Claude|ARTIFICIAL ESOPHAGUS.|

---

US4932948A|1988-03-28|1990-06-12|Hollister Incorporated|Male external catheter and antimicrobial insert therefor|

---

US4846836A|1988-10-03|1989-07-11|Reich Jonathan D|Artificial lower gastrointestinal valve|

---

AU4492989A|1988-10-20|1990-05-14|Fusen H. Chen|Incontinence device|

---

US5800339A|1989-02-09|1998-09-01|Opticon Medical Inc.|Urinary control valve|

---

US4932938A|1989-05-05|1990-06-12|Medical Engineering Corporation|Urethral indwelling catheter with incontinence control|

---

CH680263A5|1989-07-20|1992-07-31|Norman Godin|

---

US5314473A|1989-07-20|1994-05-24|Godin Norman J|Prosthesis for preventing gastric reflux into the esophagus|

---

US5088980A|1990-05-31|1992-02-18|The United States Of America As Represented By The Department Of Health And Human Services|Intra-urethral valve with integral spring|

---

US5140999A|1991-09-30|1992-08-25|Primed International Corp.|Urinary incontinence valve device|

---

US5395349A|1991-12-13|1995-03-07|Endovascular Technologies, Inc.|Dual valve reinforced sheath and method|

---

BE1006440A3|1992-12-21|1994-08-30|Dereume Jean Pierre Georges Em|Luminal endoprosthesis AND METHOD OF PREPARATION.|

---

US5536258A|1994-02-14|1996-07-16|Fresenius Usa, Inc.|Antibacterial medical tubing connector|

---

US5549657A|1994-05-12|1996-08-27|C.R. Bard, Inc.|Low profile adaptor for gastrostomy feeding tube|

---

US5624374A|1994-11-03|1997-04-29|Von Iderstein; Irwin F.|Involuntary urine control apparatus, system and method|

---

US5609629A|1995-06-07|1997-03-11|Med Institute, Inc.|Coated implantable medical device|

---

US5701916A|1995-08-16|1997-12-30|Hk Medical Technologies Incorporated|Intraurethral bladder control device with retainer apparatus|

---

US6050934A|1997-02-26|2000-04-18|Cv Dynamics, Inc.|Urinary catheter having palpitatable discharge valve with protective shoulders|

---

US5887594A|1997-09-22|1999-03-30|Beth Israel Deaconess Medical Center Inc.|Methods and devices for gastroesophageal reflux reduction|

---

US6254642B1|1997-12-09|2001-07-03|Thomas V. Taylor|Perorally insertable gastroesophageal anti-reflux valve prosthesis and tool for implantation thereof|

---

US6113609A|1998-05-26|2000-09-05|Scimed Life Systems, Inc.|Implantable tissue fastener and system for treating gastroesophageal reflux disease|

---

US6066088A|1998-07-13|2000-05-23|Phillip Davis Inventions, Inc.|Intraurethral magnetic valve|

---

WO2000012027A1|1998-08-27|2000-03-09|Endonetics, Inc.|Lower esophageal bulking device|

---

US6264700B1|1998-08-27|2001-07-24|Endonetics, Inc.|Prosthetic gastroesophageal valve|

---

ES2212623T3|1998-08-31|2004-07-16|Wilson-Cook Medical Inc.|ANTI-REFLUJO ESOFAGIC PROTESIS.|

---

US7118600B2|1998-08-31|2006-10-10|Wilson-Cook Medical, Inc.|Prosthesis having a sleeve valve|

---

US6746489B2|1998-08-31|2004-06-08|Wilson-Cook Medical Incorporated|Prosthesis having a sleeve valve|

---

US7637932B2|2001-11-28|2009-12-29|Aptus Endosystems, Inc.|Devices, systems, and methods for prosthesis delivery and implantation|

---

US6494879B2|1998-10-15|2002-12-17|Scimed Life Systems, Inc.|Treating urinary retention|

---

US6251064B1|1998-12-11|2001-06-26|Enteric Medical Technologies, Inc.|Method for creating valve-like mechanism in natural body passageway|

---

US6234956B1|1999-08-11|2001-05-22|Hongping He|Magnetic actuation urethral valve|

---

US7011094B2|2001-03-02|2006-03-14|Emphasys Medical, Inc.|Bronchial flow control devices and methods of use|

---

US20030135268A1|2000-04-11|2003-07-17|Ashvin Desai|Secure stent for maintaining a lumenal opening|

---

US6988983B2|2000-04-14|2006-01-24|Solace Therapeutics, Inc.|Implantable self-inflating attenuation device|

---

US6729356B1|2000-04-27|2004-05-04|Endovascular Technologies, Inc.|Endovascular graft for providing a seal with vasculature|

---

US6921361B2|2000-07-24|2005-07-26|Olympus Corporation|Endoscopic instrument for forming an artificial valve|

---

US6432040B1|2000-09-14|2002-08-13|Nizam N. Meah|Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method|

---

US6726696B1|2001-04-24|2004-04-27|Advanced Catheter Engineering, Inc.|Patches and collars for medical applications and methods of use|

---

US7087088B2|2001-05-24|2006-08-08|Torax Medical, Inc.|Methods and apparatus for regulating the flow of matter through body tubing|

---

US20030069635A1|2001-05-29|2003-04-10|Cartledge Richard G.|Prosthetic heart valve|

---

US6958079B1|2001-07-03|2005-10-25|Reflux Corporation|Perorally insertable/removable anti-reflux valve|

---

FR2826863B1|2001-07-04|2003-09-26|Jacques Seguin|ASSEMBLY FOR THE PLACEMENT OF A PROSTHETIC VALVE IN A BODY CONDUIT|

---

US6638253B2|2001-07-17|2003-10-28|Eugene Michael Breznock|Method and apparatus for chest drainage|

---

WO2003009773A2|2001-07-26|2003-02-06|Alveolus Inc.|Removable stent and method of using the same|

---

US7146984B2|2002-04-08|2006-12-12|Synecor, Llc|Method and apparatus for modifying the exit orifice of a satiation pouch|

---

US20040117031A1|2001-08-27|2004-06-17|Stack Richard S.|Satiation devices and methods|

---

US6845776B2|2001-08-27|2005-01-25|Richard S. Stack|Satiation devices and methods|

---

US6675809B2|2001-08-27|2004-01-13|Richard S. Stack|Satiation devices and methods|

---

US6790237B2|2001-10-09|2004-09-14|Scimed Life Systems, Inc.|Medical stent with a valve and related methods of manufacturing|

---

US6921378B2|2001-10-09|2005-07-26|Boston Scientific Scimed, Inc.|Anti-reflux drainage devices and methods|

---

US20030135265A1|2002-01-04|2003-07-17|Stinson Jonathan S.|Prostheses implantable in enteral vessels|

---

US7047980B2|2002-04-09|2006-05-23|Promethean Surgical Devices Llc|Treatment for Gastroesophageal disease|

---

US7001367B2|2002-04-16|2006-02-21|Arkinstall William W|Valved ostomy drainage device|

---

US6908447B2|2002-04-18|2005-06-21|Scimed Life Systems, Inc.|Anti-reflux ureteral stents and methods|

---

US7270675B2|2002-05-10|2007-09-18|Cordis Corporation|Method of forming a tubular membrane on a structural frame|

---

US7033384B2|2002-08-30|2006-04-25|Satiety, Inc.|Stented anchoring of gastric space-occupying devices|

---

KR100442330B1|2002-09-03|2004-07-30|주식회사 엠아이텍|Stent and manufacturing method the same|

---

EP2292637B1|2002-09-06|2016-01-06|Genentech, Inc.|Process for protein extraction|

---

US9060844B2|2002-11-01|2015-06-23|Valentx, Inc.|Apparatus and methods for treatment of morbid obesity|

---

EP2010270A4|2006-04-07|2014-07-09|Valentx Inc|Devices and methods for endolumenal gastrointestinal bypass|

---

US8282678B2|2002-11-13|2012-10-09|Allium Medical Solutions Ltd.|Endoluminal lining|

---

US7025791B2|2002-12-02|2006-04-11|Gi Dynamics, Inc.|Bariatric sleeve|

---

US6960233B1|2002-12-10|2005-11-01|Torax Medical, Inc.|Methods and apparatus for improving the function of biological passages|

---

US7025779B2|2003-02-26|2006-04-11|Scimed Life Systems, Inc.|Endoluminal device having enhanced affixation characteristics|

---

US20050049675A1|2003-03-28|2005-03-03|Board Of Regents, The University Of Texas System|Medical devices and related methods|

---

US7717952B2|2003-04-24|2010-05-18|Cook Incorporated|Artificial prostheses with preferred geometries|

---

US8034048B2|2003-05-05|2011-10-11|Boston Scientific Scimed, Inc.|Tissue patches and related delivery systems and methods|

---

US7416546B2|2003-05-05|2008-08-26|Boston Scientific Scimed, Inc.|Tissue patches and related delivery systems and methods|

---

US20070027549A1|2003-09-02|2007-02-01|Norman Godin|Gastrointestinal anti-reflux prosthesis apparatus and method|

---

US7144421B2|2003-11-06|2006-12-05|Carpenter Judith T|Endovascular prosthesis, system and method|

---

AU2004305450B2|2003-12-09|2009-01-08|Gi Dynamics, Inc.|Intestinal sleeve|

---

US8915967B2|2003-12-19|2014-12-23|Patrick Leahy|Anti reflux system|

---

US9039724B2|2004-03-19|2015-05-26|Aga Medical Corporation|Device for occluding vascular defects|

---

US20050228505A1|2004-03-29|2005-10-13|Cornet Douglas A|Device and method for treating gastroesophageal reflux disease|

---

US7470247B2|2004-04-26|2008-12-30|Gyrus Acmi, Inc.|Ureteral stent|

---

US20060135971A1|2004-05-07|2006-06-22|Usgi Medical Inc.|System for treating gastroesophageal reflux disease|

---

US7351369B2|2004-06-21|2008-04-01|King Technology|Molded twist-on wire connector|

---

US20060041189A1|2004-08-17|2006-02-23|Vancaillie Thierry G|Grummet|

---

US7833281B2|2004-12-15|2010-11-16|Lehman Glen A|Method and apparatus for augmentation of a sphincter|

---

US7766973B2|2005-01-19|2010-08-03|Gi Dynamics, Inc.|Eversion resistant sleeves|

---

FR2883721B1|2005-04-05|2007-06-22|Perouse Soc Par Actions Simpli|NECESSARY TO BE IMPLANTED IN A BLOOD CIRCULATION CONDUIT, AND ASSOCIATED TUBULAR ENDOPROTHESIS|

---

US7914569B2|2005-05-13|2011-03-29|Medtronics Corevalve Llc|Heart valve prosthesis and methods of manufacture and use|

---

US7666180B2|2005-05-20|2010-02-23|Tyco Healthcare Group Lp|Gastric restrictor assembly and method of use|

---

WO2007016097A2|2005-07-27|2007-02-08|Georgia Tech Research Corporation|Implantable prosthetic vascular valve|

---

WO2007016251A2|2005-07-28|2007-02-08|Cook Incorporated|Implantable thromboresistant valve|

---

US20070088428A1|2005-09-15|2007-04-19|Cappella, Inc.|Intraluminal device with asymmetric cap portion|

---

US7601361B2|2005-10-03|2009-10-13|E. I. Du Pont De Nemours And Company|Process for providing antimicrobial surfaces|

---

DE102005052628B4|2005-11-04|2014-06-05|Jenavalve Technology Inc.|Self-expanding, flexible wire mesh with integrated valvular prosthesis for the transvascular heart valve replacement and a system with such a device and a delivery catheter|

---

US20080275540A1|2005-11-09|2008-11-06|Ning Wen|Artificial Heart Valve Stent and Weaving Method Thereof|

---

CN100362971C|2005-11-16|2008-01-23|程英升|Cardia stent|

---

EP1968487B1|2005-12-23|2019-06-26|Coloplast A/S|Medical device|

---

RU59402U1|2005-12-28|2006-12-27|Валерий Андреевич Черкасов|STENT FOR CREATING OR CLOSING THE JOINTS|

---

WO2007079153A2|2005-12-29|2007-07-12|Wilson-Cook Medical Inc.|A hybrid intraluminal device with varying expansion force|

---

EP1976575A2|2006-01-31|2008-10-08|Angiotech BioCoatings, Corp.|Lubricious echogenic coatings|

---

WO2007107990A2|2006-03-20|2007-09-27|Svip 2 Llc|Pyloric devices and methods|

---

US7524331B2|2006-04-06|2009-04-28|Medtronic Vascular, Inc.|Catheter delivered valve having a barrier to provide an enhanced seal|

---

US7819836B2|2006-06-23|2010-10-26|Gi Dynamics, Inc.|Resistive anti-obesity devices|

---

US20080051879A1|2006-08-23|2008-02-28|Cook Incorporated|Methods of treating venous valve related conditions with a flow-modifying implantable medical device|

---

WO2008028037A2|2006-08-30|2008-03-06|Andrew Young|Distender device and method for treatment of obesity and metabolic and other diseases|

---

US20080082165A1|2006-09-28|2008-04-03|Heart Leaflet Technologies, Inc.|Delivery Tool For Percutaneous Delivery Of A Prosthesis|

---

WO2008046092A2|2006-10-13|2008-04-17|Creighton University|Implantable valve prosthesis|

---

US8105392B2|2006-11-08|2012-01-31|Boston Scientific Scimed, Inc.|Pyloric obesity valve|

---

US7678144B2|2007-01-29|2010-03-16|Cook Incorporated|Prosthetic valve with slanted leaflet design|

---

US8529431B2|2007-02-14|2013-09-10|Bfkw, Llc|Bariatric device and method|

---

EP2134303A1|2007-03-29|2009-12-23|Jaime Vargas|Intragastric implant devices|

---

US20080255678A1|2007-04-13|2008-10-16|Cully Edward H|Medical apparatus and method of making the same|

---

ES2856081T3|2007-04-16|2021-09-27|Occlutech Holding Ag|Occlusor for the occlusion of an atrial appendage and its production procedure|

---

WO2009045334A1|2007-09-28|2009-04-09|St. Jude Medical, Inc.|Collapsible/expandable prosthetic heart valves with native calcified leaflet retention features|

---

WO2009045331A1|2007-09-28|2009-04-09|St. Jude Medical, Inc.|Two-stage collapsible/expandable prosthetic heart valves and anchoring systems|

---

US9532868B2|2007-09-28|2017-01-03|St. Jude Medical, Inc.|Collapsible-expandable prosthetic heart valves with structures for clamping native tissue|

---

US7806921B2|2007-11-08|2010-10-05|Cook Incorporated|Monocusp valve design|

---

US8100962B2|2008-01-08|2012-01-24|Cook Medical Technologies Llc|Flow-deflecting prosthesis for treating venous disease|

---

CA2714062A1|2008-01-24|2009-07-30|Medtronic, Inc.|Stents for prosthetic heart valves|

---

US8747453B2|2008-02-18|2014-06-10|Aga Medical Corporation|Stent/stent graft for reinforcement of vascular abnormalities and associated method|

---

JP2011512948A|2008-02-25|2011-04-28|メドトロニックカルディオヴァスキュラーインコーポレイテッド|Funnel reduction tool|

---

US7806919B2|2008-04-01|2010-10-05|Medtronic Vascular, Inc.|Double-walled stent system|

---

US8100850B2|2008-04-09|2012-01-24|E2 Llc|Pyloric valve devices and methods|

---

WO2009126268A1|2008-04-09|2009-10-15|Endocore Llc|Pyloric valve|

---

WO2009130619A1|2008-04-23|2009-10-29|Duocure, Inc.|Duodenal liner device|

---

CN102083391B|2008-04-23|2015-02-18|麦德托尼克公司|Stented heart valve devices|

---

US20090270971A1|2008-04-24|2009-10-29|Medtronic Vascular, Inc.|Prosthesis Fixation Apparatus and Methods|

---

US10350050B2|2008-05-01|2019-07-16|Ethicon Endo-Surgery, Inc.|Method for gastric volume reduction surgery|

---

CA2724624C|2008-05-16|2017-01-17|Maurice Garcia|Catheter drainage system|

---

EP2337522B1|2008-06-20|2014-06-11|Vysera Biomedical Limited|Esophageal valve|

---

EP3311777B1|2008-06-20|2020-11-18|Coloplast A/S|A biomaterial|

---

WO2010011878A2|2008-07-24|2010-01-28|Cook Incorporated|Valve device with biased leaflets|

---

US20100030321A1|2008-07-29|2010-02-04|Aga Medical Corporation|Medical device including corrugated braid and associated method|

---

US7951111B2|2008-10-10|2011-05-31|Intervalve, Inc.|Valvuloplasty catheter and methods|

---

US20100131049A1|2008-11-24|2010-05-27|Medtronic Vascular, Inc.|One-Way valve Prosthesis for Percutaneous Placement Within the Venous System|

---

AU2010232570B2|2009-04-03|2013-11-14|Metamodix, Inc.|Modular gastrointestinal prostheses|

---

US20120065571A1|2009-04-03|2012-03-15|Metamodix, Inc.|Expandable pyloric anchors and methods for securing intestinal bypass sleeves|

---

US20100312225A1|2009-06-03|2010-12-09|John Anderson Armistead|Wholly indwelling, valve-actuated, urinary catheter|

---

AU2010271294B2|2009-07-10|2015-09-03|Metamodix, Inc.|External anchoring configurations for modular gastrointestinal prostheses|

---

US8845722B2|2009-08-03|2014-09-30|Shlomo Gabbay|Heart valve prosthesis and method of implantation thereof|

---

US9877860B2|2009-10-26|2018-01-30|Apollo Endosurgery Us, Inc.|Bariatric device and method for weight loss|

---

US8512313B2|2009-11-03|2013-08-20|Advanced Urological Products|Urinary flow control valve with pressure sealing|

---

PT2513200T|2009-12-18|2018-06-11|Coloplast As|A biomaterial|

---

US20120158026A1|2009-12-18|2012-06-21|Vysera Biomedical Limited|Gastrointestinal implant device|

---

US20130006382A1|2009-12-18|2013-01-03|Vysera Biomedical Limited|Gastrointestinal implant device|

---

US20120310138A1|2009-12-18|2012-12-06|Vysera Biomedical Limited|Gastrointestinal implant device and delivery system therefor|

---

IE20100789A1|2009-12-18|2011-08-03|Vysera Biomedical Ltd|A medical device|

---

US8409269B2|2009-12-21|2013-04-02|Covidien Lp|Procedures for vascular occlusion|

---

JP2011224123A|2010-04-19|2011-11-10|Kanji Inoue|Stent|

---

EP2563295B1|2010-04-30|2020-07-01|Boston Scientific Scimed, Inc.|Stent for repair of anastomasis surgery leaks|

---

WO2012003150A1|2010-06-28|2012-01-05|Cook Medical Technologies Llc|Covered stent|

---

KR20120004677A|2010-07-07|2012-01-13| 태웅메디칼|Using two kinds of tissue heart valve prostheses and manufacturing methods|

---

US20120095384A1|2010-10-19|2012-04-19|Allergan, Inc.|Stomach-spanning gastric implants|

---

US8696741B2|2010-12-23|2014-04-15|Maquet Cardiovascular Llc|Woven prosthesis and method for manufacturing the same|

---

EP2478868A1|2011-01-25|2012-07-25|The Provost, Fellows, Foundation Scholars, and the other Members of Board, of the College of the Holy and Undivided Trinity of Queen Elizabeth|Implant device|

---

US8511214B2|2011-04-21|2013-08-20|Aga Medical Corporation|Tubular structure and method for making the same|

---

AU2012259125B2|2011-05-20|2016-06-02|Bfkw, Llc|Intraluminal device and method with enhanced anti-migration|

---

US8852272B2|2011-08-05|2014-10-07|Mitraltech Ltd.|Techniques for percutaneous mitral valve replacement and sealing|

---

EP2785276A4|2011-12-01|2015-08-12|Woodstock Man Pty Ltd|Endoluminal prosthesis|

---

WO2013092715A2|2011-12-19|2013-06-27|Vysera Biomedical Limited|A luminal prosthesis and a gastrointestinal implant device|

---

CA2908948C|2013-02-28|2019-02-26|Boston Scientific Scimed, Inc.|Stent with balloon for repair of anastomosis surgery leaks|

---

US9867697B2|2013-03-12|2018-01-16|St. Jude Medical, Cardiology Division, Inc.|Self-actuating sealing portions for a paravalvular leak protection|

---

US9398951B2|2013-03-12|2016-07-26|St. Jude Medical, Cardiology Division, Inc.|Self-actuating sealing portions for paravalvular leak protection|

---

US9339274B2|2013-03-12|2016-05-17|St. Jude Medical, Cardiology Division, Inc.|Paravalvular leak occlusion device for self-expanding heart valves|

---

CA2910753A1|2013-03-13|2014-10-09|Aortic Innovations, Llc|Dual frame stent and valve devices and implantation|

---

CA2892269C|2013-03-15|2021-05-25|Merit Medical Systems, Inc.|Esophageal stent|

---

EP2896387A1|2014-01-20|2015-07-22|Mitricares|Heart valve anchoring device|

---

EP3128960A1|2014-04-08|2017-02-15|Boston Scientific Scimed, Inc.|Partially coated stents|

---

EP3193780A1|2014-09-18|2017-07-26|Boston Scientific Scimed Inc.|Device allowing pyloric sphincter to normally function for bariatric stents|US7608114B2|2002-12-02|2009-10-27|Gi Dynamics, Inc.|Bariatric sleeve|

---

US7025791B2|2002-12-02|2006-04-11|Gi Dynamics, Inc.|Bariatric sleeve|

---

AU2004305450B2|2003-12-09|2009-01-08|Gi Dynamics, Inc.|Intestinal sleeve|

---

EP2240215B1|2008-01-17|2014-01-08|Boston Scientific Scimed, Inc.|Stent with anti-migration feature|

---

AU2010232570B2|2009-04-03|2013-11-14|Metamodix, Inc.|Modular gastrointestinal prostheses|

---

US9173760B2|2009-04-03|2015-11-03|Metamodix, Inc.|Delivery devices and methods for gastrointestinal implants|

---

EP3352712A4|2015-09-23|2019-07-31|SynerZ Medical, Inc.|Intragastric device for treating obesity|

---

FR2978345B1|2011-07-25|2013-08-30|Charam Khosrovaninejad|SURGICAL DEVICE FOR ANCHOR CONTROL IN INTESTINES.|

---

WO2013092715A2|2011-12-19|2013-06-27|Vysera Biomedical Limited|A luminal prosthesis and a gastrointestinal implant device|

---

WO2014113483A1|2013-01-15|2014-07-24|Metamodix, Inc.|System and method for affecting intestinal microbial flora|

---

WO2014138006A1|2013-03-05|2014-09-12|Merit Medical Systems, Inc.|Reinforced valve|

---

CN103705326A|2013-12-27|2014-04-09|成都中医药大学附属医院|Support, endoscope package and support releasing method|

---

EP3193780A1|2014-09-18|2017-07-26|Boston Scientific Scimed Inc.|Device allowing pyloric sphincter to normally function for bariatric stents|

---

CN104546248A|2015-01-16|2015-04-29|复旦大学附属中山医院|Stomach and intestine absorption resisting isolating membrane|

---

US20160235525A1|2015-02-12|2016-08-18|Medtronic, Inc.|Integrated valve assembly and method of delivering and deploying an integrated valve assembly|

---

CA2977681A1|2015-03-05|2016-09-09|Merit Medical Systems, Inc.|Vascular prosthesis deployment device and method of use|

---

CN105055062A|2015-06-03|2015-11-18|常州新区佳森医用支架器械有限公司|Duodenum stent, preparation method, mould, stent implantation instrument and binding method|

---

US10507128B2|2015-11-17|2019-12-17|Boston Scientific Scimed, Inc.|Devices and methods for reducing absorption|

---

DE102016101273A1|2016-01-25|2017-07-27|Christian-Albrechts-Universität Zu Kiel|Stent graft system and a method for coupling stent graft as a stent-graft system|

---

GB2548086B|2016-03-01|2020-01-29|Strait Access Tech Holdings Pty Ltd|An inflatable insertion device for percutaneous insertion|

---

US9622897B1|2016-03-03|2017-04-18|Metamodix, Inc.|Pyloric anchors and methods for intestinal bypass sleeves|

---

DE202017007388U1|2016-05-19|2021-02-12|Metamodix, Inc.|Tools for pyloric anchor recovery|

---

CN109789025A|2016-09-29|2019-05-21|美国医疗设备有限公司|For receiving and assisting the flexible members of allotment blood vessel prosthesis|

---

CN106726000B|2016-12-22|2018-03-06|中国人民解放军第二军医大学|Alimentary canal connector for reconstruction of digestive tract in duodenectomy|

---

US10736764B2|2017-01-30|2020-08-11|Apollo Endosurgery Us, Inc.|Duodenal sleeve and anchor and methods of implantation|

---

WO2018160851A1|2017-03-02|2018-09-07|Boston Scientific Scimed, Inc.|Esophageal stent including an inner liner|

---

EP3595594A4|2017-03-15|2021-04-21|Merit Medical Systems, Inc.|Transluminal stents and related methods|

---

USD836194S1|2017-03-21|2018-12-18|Merit Medical Systems, Inc.|Stent deployment device|

---

KR20210149248A|2017-03-28|2021-12-08|보스톤 싸이엔티픽 싸이메드 인코포레이티드|System for treating a body lumen|

---

US11013889B2|2017-05-03|2021-05-25|Boston Scientific Scimed, Inc.|Medical device with sealing assembly|

---

RU184121U1|2017-10-06|2018-10-16|Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации |STENT SELF-EXTENDING COLORECTAL|

---

US20190117370A1|2017-10-25|2019-04-25|Boston Scientific Scimed, Inc.|Stent with atraumatic spacer|

---

CN111315319A|2017-11-01|2020-06-19|波士顿科学国际有限公司|Esophageal stent comprising valve member|

---

EP3706619A1|2017-11-09|2020-09-16|11 Health and Technologies Limited|Ostomy monitoring system and method|

---

KR102112820B1|2017-12-01|2020-05-19|주식회사 비씨엠|A Stent|

---

US11033411B2|2017-12-14|2021-06-15|Boston Scientific Scimed, Inc.|Stent including an expandable member|

---

US10327938B1|2018-05-23|2019-06-25|Allium Medical Solutions Ltd.|Intestinal sleeve|

---

USD893514S1|2018-11-08|2020-08-18|11 Health And Technologies Limited|Display screen or portion thereof with graphical user interface|

---

KR102223068B1|2019-04-02|2021-03-04|주식회사 비씨엠|A Stent|

---

KR20210052744A|2019-10-31|2021-05-11|주식회사 삼양바이오팜|Stent for non vascular use|

法律状态:
2018-03-20| B25A| Requested transfer of rights approved|Owner name: COLOPLAST A/S (DK) |

---

2019-11-26| B06U| Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette]|

---

2020-09-24| B07A| Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]|

---

2021-02-17| B09A| Decision: intention to grant [chapter 9.1 patent gazette]|

---

2021-05-04| B16A| Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]|Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 19/12/2012, OBSERVADAS AS CONDICOES LEGAIS. |

优先权:

---

申请号 | 申请日 | 专利标题

---

US201161577308P| true| 2011-12-19|2011-12-19|

---

US201161577302P| true| 2011-12-19|2011-12-19|

---

US61/577,308|2011-12-19|

---

US61/577,302|2011-12-19|

---

US201261641804P| true| 2012-05-02|2012-05-02|

---

US61/641,804|2012-05-02|

---

IE20120508|2012-11-26|

---

IE2012/0508|2012-11-26|

---

PCT/EP2012/076153|WO2013092715A2|2011-12-19|2012-12-19|A luminal prosthesis and a gastrointestinal implant device|

---